Amedeo Smart

Free Medical Literature Service

 

Amedeo

HIV Infection
  Free Subscription

Articles published in
AIDS
    May 2026
  1. SAWATZKY J, Conroy AL, Brochon J, Kakkar F, et al
    Dysregulation of circulating angiopoietins is associated with low birth weight in children who are HIV-exposed and uninfected.
    AIDS. 2026;40:696-699.
    >> Share

  2. RUBIN LH, Maki PM, Du Y, Dastgheyb RM, et al
    Stability of the translocator protein 18 kDa density within cognitive circuits in brains of virally-suppressed people with HIV.
    AIDS. 2026;40:693-696.
    >> Share

  3. BONO V, Tincati C, Augello M, Rovito R, et al
    Age and viral replication, not vertical HIV acquisition, drive inflammation and T-cell dysfunction in heavily treatment experienced: data from the Prestigio Registry.
    AIDS. 2026;40:690-693.
    >> Share

    April 2026
  4. PALICH R, Pelchen-Matthews A, Kall M, Sewell J, et al
    Belief in the 'Undetectable equals Untransmissible'(U=U) statement and associations with stigma, mental health and sexual satisfaction in people living with HIV (PWH) in the UK.
    AIDS. 2026 Apr 7. doi: 10.1097/QAD.0000000000004517.
    >> Share

  5. SINGH M, Nyandiko W, DeLong A, Ashimosi C, et al
    Longitudinal challenges faced by perinatally-infected young people living with HIV in Kenya during the COVID-19 pandemic.
    AIDS. 2026 Apr 7. doi: 10.1097/QAD.0000000000004518.
    >> Share

  6. PARK H, Hyle EP, Tassiopoulos KK, Gisslen M, et al
    Quantifying brain-age gap in people with HIV on antiretroviral therapy using plasma neurofilament light chain.
    AIDS. 2026 Apr 7. doi: 10.1097/QAD.0000000000004519.
    >> Share

  7. CROSS S, Levi J, Venter F, Hill A, et al
    The estimated cost of MK-8527 produced at scale for once-monthly oral HIV pre-exposure prophylaxis (PrEP) in low- and middle-income countries.
    AIDS. 2026 Apr 2. doi: 10.1097/QAD.0000000000004487.
    >> Share

  8. PESSOA FS
    Brazil's historic achievement: WHO certification for eliminating mother-to-child transmission of HIV in a continental nation.
    AIDS. 2026;40:539-540.
    >> Share

  9. ZALESAK A, Schnure M, Forster R, Jones JL, et al
    Targeted cuts to Ryan White programs could raise HIV incidence by 8-17% in 30 US states and the District of Columbia.
    AIDS. 2026;40:536-538.
    >> Share

  10. RUBIN LH, Chandra A, Alt J, Dastgheyb RM, et al
    N-acetyl-aspartyl-glutamate connects neuroinflammatory signatures to attention and working memory in people with HIV.
    AIDS. 2026;40:532-535.
    >> Share

  11. TAO K, Tzou PL, Sahoo MK, Hare CB, et al
    HIV-1 subtype diversity trends in a Northern California cohort.
    AIDS. 2026;40:530-532.
    >> Share

  12. GOODKIN K, Dorfman D
    Social cognition in people with HIV: a neglected cognitive domain?
    AIDS. 2026;40:525-529.
    >> Share

  13. SOUDEYNS H
    High risk of reacquisition of hepatitis C virus infection in people with HIV with continued risk behavior.
    AIDS. 2026;40:519-521.
    >> Share

    March 2026
  14. MASON J, Kohli M, Taiwo E, Maan I, et al
    Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIV.
    AIDS. 2026 Mar 31. doi: 10.1097/QAD.0000000000004508.
    >> Share

  15. GIOVENCO D, Rousseau E, Wallace M, Bekker LG, et al
    Unraveling PrEP persistence: mental health and substance use among adolescent girls and young women in a PrEP implementation program.
    AIDS. 2026 Mar 31. doi: 10.1097/QAD.0000000000004509.
    >> Share

  16. GARCIA-ABELLAN J, Garcia JA, Padilla S, Fernandez-Gonzalez M, et al
    Contribution of hepatic steatosis to subclinical atherosclerosis progression in people with HIV receiving integrase inhibitors: A 5-Year prospective cohort study.
    AIDS. 2026 Mar 31. doi: 10.1097/QAD.0000000000004512.
    >> Share

  17. SANTERRE M, Allen CNS, Arjona SP, Shcherbik N, et al
    HIV-1 gp120 exposure associates with mitochondrial and PKM remodeling in cardiomyocytes.
    AIDS. 2026 Mar 31. doi: 10.1097/QAD.0000000000004507.
    >> Share

  18. FILIP I
    Can scientific innovation translate into real-world impact in the era of diversified HIV prevention choices?
    AIDS. 2026 Mar 27. doi: 10.1097/QAD.0000000000004515.
    >> Share

  19. KEKITIINWA AR, Juma M, Tumusiime C, Ssebunya RN, et al
    Integrating tuberculosis services with the Orphans and Vulnerable Children Program in Rwenzori region, Uganda, 2022-2023.
    AIDS. 2026 Mar 26. doi: 10.1097/QAD.0000000000004503.
    >> Share

  20. CROMHOUT GZ, Bengu N, Herbert NG, Fillis R, et al
    Increases in total HIV-1 nucleic acid in whole blood precede plasma rna rebound during paediatric analytical treatment interruption.
    AIDS. 2026 Mar 26. doi: 10.1097/QAD.0000000000004506.
    >> Share

  21. LAHIRI CD, Soibi-Harry AP, Musonge-Effoe J, Alvarez JA, et al
    Association between plasma concentrations of integrase strand transfer inhibitors and body weight gain in women living with HIV.
    AIDS. 2026 Mar 26. doi: 10.1097/QAD.0000000000004496.
    >> Share

  22. AIZIRE KJ, Lewis L, Pettifor JM, Atuhaire P, et al
    Bone turnover marker trajectories in postpartum women living with HIV compared to women without HIV.
    AIDS. 2026 Mar 26. doi: 10.1097/QAD.0000000000004489.
    >> Share

  23. GUILAMO-RAMOS V, Thimm-Kaiser M, Benzekri A, Stafford SR, et al
    The price of invisibility: a cascading disaster in the US Latino HIV epidemic.
    AIDS. 2026 Mar 26. doi: 10.1097/QAD.0000000000004493.
    >> Share

  24. HWANG YJ, Lesko CR, Brown TT, Alexander GC, et al
    Changes in weight and glycemia after initiation of integrase strand transfer inhibitors among people with HIV and diabetes in the United States and Canada.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004502.
    >> Share

  25. CHALOUNI M, Torgersen J, Rentsch CT, Van Santen DK, et al
    Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIV.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004499.
    >> Share

  26. METE ATASEVER N, Dede E, Yilmaz S, Akkoc G, et al
    Meningococcal and pneumococcal carriage in children living with HIV: a multi-center prospective study from Turkiye (MENPHIV-TR study).
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004500.
    >> Share

  27. MCFARLANE WJ, Brogly SB, Flemming JA, Martinez-Cajas J, et al
    HIV-sex interaction effect on risk of hepatitis C-related cirrhosis, decompensation, and hepatocellular carcinoma.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004501.
    >> Share

  28. AUNG HL, Patel P, Gray RT, Asselin J, et al
    Sustained viral suppression among people living with HIV in the era of Undetectable = Untransmittable (U = U) in Australia.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004488.
    >> Share

  29. CHEN T, Chen X, Wang S, Wang L, et al
    Male-specific association of HIV infection with lower risk of hyperuricemia is mediated by lower BMI and AGR.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004490.
    >> Share

  30. PENNETZDORFER N, Naik V, Montezuma-Rusca JM, Sklar P, et al
    Baseline and week 48 resistance analysis in participants receiving bictegravir + lenacapavir in the phase 2 ARTISTRY-1 study.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004495.
    >> Share

  31. KWOK M, Dandapani H, Ibrahim N, Bloomfield GS, et al
    Estimating the degree of cardiovascular disease risk under-prediction in people living with HIV by existing risk models: an updated meta-analysis.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004492.
    >> Share

  32. BAILIN SS, Gabriel CL, Gangula RD, Hannah L, et al
    Adipose tissue microvascular is linked to insulin resistance and lipidome alterations in treated HIV.
    AIDS. 2026 Mar 24. doi: 10.1097/QAD.0000000000004491.
    >> Share

  33. TROYA J, Montes ML, Galindo MJ, Sanchez-Lopez MB, et al
    Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the RELATIVITY cohort.
    AIDS. 2026 Mar 10. doi: 10.1097/QAD.0000000000004484.
    >> Share

  34. ANESTEN B, Zetterberg H, Nilsson S, Fuchs D, et al
    Comprehensive study of cerebrospinal fluid beta2-microglobulin, a marker of central nervous system immune activation in individuals with HIV.
    AIDS. 2026 Mar 6. doi: 10.1097/QAD.0000000000004482.
    >> Share

  35. HENDRIX CW, Hillier SL, Bekker LG, Badal-Faesen S, et al
    Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosing.
    AIDS. 2026 Mar 6. doi: 10.1097/QAD.0000000000004477.
    >> Share

  36. NYEIN PP, Donoghoe MW, Eriobu N, Uche B, et al
    Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial.
    AIDS. 2026 Mar 3. doi: 10.1097/QAD.0000000000004476.
    >> Share

  37. SAH SS, Kumbhalwar A
    Letter to the editor regarding 'Post antiretroviral treatment dynamics of blood Epstein-Barr DNA among people with HIV'.
    AIDS. 2026;40:402-403.
    >> Share

  38. MACIAS-GONZALEZ F, Vermandere H, Pineirua-Menendez A, Bautista-Arredondo S, et al
    Who is accessing PrEP in Mexico? Profiling users and identifying the unreached among high-risk MSM.
    AIDS. 2026;40:397-401.
    >> Share

  39. DOS SANTOS AP, Oliveira VHF, Willig AL, Ruderman SA, et al
    Influence of the low-frequency extension filter on accelerometer-based activity measurements in people with HIV: a comparative analysis.
    AIDS. 2026;40:394-396.
    >> Share

  40. ABRESCIA N
    Menopause and metabolic risk in women with HIV: beyond antiretroviral therapy.
    AIDS. 2026;40:392-393.
    >> Share

    February 2026
  41. ENRIQUEZ CANTO Y
    Clinical composition of HIV/AIDS-related deaths during the COVID-19 pandemic: a nationwide natural experiment (2017-2024).
    AIDS. 2026 Feb 25. doi: 10.1097/QAD.0000000000004472.
    >> Share

  42. PANG X, Tang K, He Q, Ma J, et al
    Longitudinal molecular network analysis in Guangxi: implications for HIV control.
    AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004474.
    >> Share

  43. SUBIA P, Jiang X
    The impact of APOE epsilon4 on cognitive performance in adults with HIV: a systematic review and meta-analysis.
    AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004473.
    >> Share

  44. LV J, Feng L, Gao L, Yin Z, et al
    Gray matter asymmetry alterations in perinatally HIV-exposed adolescents: evidence from structural neuroimaging.
    AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004467.
    >> Share

  45. BARR E, Abuogi L, Lingwall M, Qian Q, et al
    Breastfeeding support for women with HIV: lactation consultant HIV-knowledge, attitudes, stigma, and tele-lactation experiences.
    AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004466.
    >> Share

  46. CICCULLO A, Iannone V, Giacomelli A, Baldin G, et al
    Changes in cardiovascular and metabolic risk scores after switching to DOR/3TC/TDF, DTG/3TC or BIC/FTC/TAF: results from a multicenter Italian cohort.
    AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004468.
    >> Share

  47. CRANE HM, Dai M, Fredericksen R, Drumright LN, et al
    Routine collection of patient-reported outcomes in HIV clinics: lessons learned after more than 130,000 assessments have been completed.
    AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004470.
    >> Share

  48. GHYS PD, Voetsch AC, Justman JE, Patel H, et al
    HIV-1 variants in population-based national surveys in sub-Saharan Africa, 2015-2022.
    AIDS. 2026 Feb 17. doi: 10.1097/QAD.0000000000004471.
    >> Share

  49. PAGKAS-BATHER JV, Motley DN, Balthazar C, Schneider JA, et al
    BIG Cuts, BIG Solutions: The Case for Basic Income Guarantee for Low Income People with HIV.
    AIDS. 2026 Feb 12. doi: 10.1097/QAD.0000000000004460.
    >> Share

  50. JAIN A, Liou ML, Xiao L, Canepa GE, et al
    Impact of AGT103-T cell and gene therapy on intact HIV proviral reservoirs.
    AIDS. 2026 Feb 11. doi: 10.1097/QAD.0000000000004459.
    >> Share

  51. LINDHARDT MS, Jensen LR, Meddis A, Gluud LL, et al
    Metabolic dysfunction-associated steatotic liver disease linked to antiretroviral exposure in cohort of people with HIV.
    AIDS. 2026 Feb 11. doi: 10.1097/QAD.0000000000004462.
    >> Share

  52. NCHINDA N, Hemelaar J
    Neonatal mortality attributable to preterm births associated with maternal HIV infection in sub-Saharan Africa, 1990-2020.
    AIDS. 2026 Feb 11. doi: 10.1097/QAD.0000000000004463.
    >> Share

  53. SCONZA R, Taylor GP, Ene L, Kahlert C, et al
    Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy.
    AIDS. 2026 Feb 11. doi: 10.1097/QAD.0000000000004461.
    >> Share

  54. FLYNN DW, Fairhead C, Heath K, Hill A, et al
    HIV self-testing and clinician-administered testing in Southern Africa: a systematic review of programmatic outcomes.
    AIDS. 2026 Feb 10. doi: 10.1097/QAD.0000000000004458.
    >> Share

  55. MOUSSE AH, Bregigeon S, Hocqueloux L, Menard A, et al
    Factors associated with penicillin and sulfonamide allergy and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    AIDS. 2026 Feb 9. doi: 10.1097/QAD.0000000000004457.
    >> Share

  56. AGARAWAL S, Samanta J, Chauhan RS, Kathrani N, et al
    Paradoxical tuberculosis-immune reconstitution inflammatory response syndrome after antituberculous drug modification in HIV with dual central nervous system infections.
    AIDS. 2026;40:267-269.
    >> Share

  57. MACBAIN E, Conroy AL, Brophy J, Kakkar F, et al
    Chitinase-3-like 1 is associated with stunting and developmental delay in HIV-exposed but uninfected Ugandan children.
    AIDS. 2026;40:263-266.
    >> Share

  58. APOLIANO CF, de Oliveira ACS, Folgosi VA, Prates GS, et al
    Elevated sCD14 in cerebrospinal fluid: a surrogate marker for HIV-associated neurocognitive disorders in Brazil.
    AIDS. 2026;40:260-263.
    >> Share

  59. WOOLLEY IJ
    Hyping up hypertension and HIV.
    AIDS. 2026;40:254-255.
    >> Share

  60. WOOD BR
    Doravirine/islatravir for heavily treatment-experienced adults with HIV: promise interrupted.
    AIDS. 2026;40:252-253.
    >> Share

  61. KUHN L, Brennan AT
    No cause for complacency regarding health of children who are HIV-exposed but uninfected.
    AIDS. 2026;40:249-251.
    >> Share

    January 2026
  62. AL-YASIRI L, Gill MJ, Krentz H, McMillan J, et al
    Impaired CD4+ T-cell and CD4+/CD8+ ratio recovery among people with HIV on antiretroviral therapy: prevalence and risk factors.
    AIDS. 2026 Jan 29. doi: 10.1097/QAD.0000000000004456.
    >> Share

  63. MOYLE G, Assoumou L, De Castro N, Post FA, et al
    Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/mL and history of K103N mutation.
    AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004451.
    >> Share

  64. AVEDISSIAN SN, McCarthy C, Bosch RJ, Spudich S, et al
    A novel measure of antiretroviral activity in CSF and association with HIV persistence and cognitive function.
    AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004453.
    >> Share

  65. FRASER H, Stone J, Zienkiewicz A, Lim AG, et al
    Modelling the impact of underage and coerced entry into sex work on HIV transmission in Tijuana, Mexico.
    AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004452.
    >> Share

  66. VAN DYKE RB, Sawyer GW, Williams PL, Yu W, et al
    Longitudinal assessment of inflammatory biomarkers among youth living with perinatal HIV infection and HIV exposure.
    AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004454.
    >> Share

  67. BOROK MZ, Fiorillo S, Manyeruke F, Makoni T, et al
    Improved screening for pulmonary Kaposi sarcoma in a low-resource setting.
    AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004455.
    >> Share

  68. HOSANGADI D, Mine M, West CA, Selato R, et al
    Non-communicable disease burden among adults with and without HIV in Botswana.
    AIDS. 2026 Jan 20. doi: 10.1097/QAD.0000000000004449.
    >> Share

  69. WYEN C, Jonsson-Oldenbuttel C, Noe S, Borch J, et al
    Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1.
    AIDS. 2026 Jan 20. doi: 10.1097/QAD.0000000000004448.
    >> Share

  70. SULLIVAN K, Chatani-Gada M, Lievense B, Slack C, et al
    Advancing ethical biomedical HIV prevention research for pregnant and lactating people: a collaborative approach.
    AIDS. 2026 Jan 20. doi: 10.1097/QAD.0000000000004447.
    >> Share

  71. ROUSH SM, Beck S, Coelho J, Chirwa A, et al
    Mutational profiling of HIV+ diffuse large B-cell lymphoma reveals distinct mutational features with evidence of genomic instability.
    AIDS. 2026 Jan 20. doi: 10.1097/QAD.0000000000004443.
    >> Share

  72. CORDOVA E, Rendon JH, Calderon GA, Seleme S, et al
    Efficacy of dolutegravir plus lamivudine in treatment-naive people with HIV with baseline transmitted drug-resistance mutations.
    AIDS. 2026 Jan 15. doi: 10.1097/QAD.0000000000004444.
    >> Share

  73. HARRICHANDPARSAD R, Lustig G, Sviridchik V, Jule Z, et al
    Cerebrospinal fluid proteomics reveals inflammatory activation in aneurysmal subarachnoid hemorrhage irrespective of HIV status.
    AIDS. 2026 Jan 15. doi: 10.1097/QAD.0000000000004445.
    >> Share

  74. FILIP I
    HIV-specific screening strategies may enhance detection of liver fibrosis in high-risk individuals.
    AIDS. 2026 Jan 7. doi: 10.1097/QAD.0000000000004441.
    >> Share

  75. KULCHYNSKA R, Sazonova Y, Azarskova M, Salyuk T, et al
    Sex disparities and partners' positive HIV status in HIV recent infection among people who inject drugs in Ukraine.
    AIDS. 2026 Jan 6. doi: 10.1097/QAD.0000000000004440.
    >> Share

  76. DUARTE MJ, Tien PC, Kardashian A, Ma Y, et al
    Erratum: Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV.
    AIDS. 2026;40:132.
    >> Share

  77. BROWN MJ, Murtala NM, Amoatika D, Kaur A, et al
    Erratum: Clinical and sociodemographic characteristics of Alzheimer's disease and related dementias among people with HIV.
    AIDS. 2026;40:131.
    >> Share

  78. KOVALENKO G, Liulchuk MG, Filippovych M, Smyrnov P, et al
    VANTAGE: van-based real-time HIV sequencing for transmission mapping and drug resistance profiling in war-affected Ukraine.
    AIDS. 2026;40:123-126.
    >> Share

  79. FREITAS C, Cooper CL, Kroch AE, Buchan SA, et al
    SARS-CoV-2 breakthrough infection among people with and without HIV in Ontario, Canada.
    AIDS. 2026;40:119-122.
    >> Share

  80. CHAN PA, Mena L, Maynard MA
    Long-acting injectable lenacapavir for HIV prevention: clinical considerations during implementation.
    AIDS. 2026;40:116-118.
    >> Share

  81. DOMINGO P, Stapleton JT
    The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization.
    AIDS. 2026;40:111-113.
    >> Share

    December 2025
  82. ALAGARATNAM J, Bakewell N, Kunisaki KM, Mallon PWG, et al
    Associations between plasma biomarkers and changes in cognitive function over two years in people with and without HIV.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004435.
    >> Share

  83. BLANKENBERGER J, Devendra A, Bakaya M, Lee T, et al
    Tolerability of lopinavir versus dolutegravir in children and adolescents with HIV (LoDoCA): a prospective cohort study in lesotho, Southern Africa.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004432.
    >> Share

  84. SHENG Q, Olumefun S, Peter O, Akhigbe P, et al
    Cognitive performance in adolescents with perinatally-acquired HIV and associations with oral health in Nigeria.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004429.
    >> Share

  85. SCHEIER TC, De Gouveia K, Engel ME, Hohlfeld AS, et al
    One-year mortality among adults with advanced HIV in sub-Saharan Africa: a systematic review and meta-analysis.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004431.
    >> Share

  86. FLICK RJ, Masiano SP, Tembo TA, Sykes C, et al
    Novel application of DBS tenofovir diphosphate to predict viral suppression in postpartum women living with HIV in Malawi.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004433.
    >> Share

  87. SHILABYE PS, Scheuermaier K, Umunnakwe CN, Barth RE, et al
    HIV and ART status at baseline are associated longitudinally with increased pulse wave velocity: findings from the Ndlovu cohort study.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004428.
    >> Share

  88. WILLEMSTEIN IJM, Prins M, Wijstma E, Van Sighem A, et al
    Estimating the HIV PrEP care continuum among gay, bisexual and other men who have sex with men in Amsterdam and the Netherlands, 2023.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004430.
    >> Share

  89. PADILLA S, Ledesma C, Fernandez-Gonzalez M, Perez-Calvo F, et al
    Point-of-care ultrasound guidance for long-acting cabotegravir-rilpivirine administration improves injection-site tolerability and preserves pharmacokinetics.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004437.
    >> Share

  90. PLAISY MK, Mondoka C, Moreira R, Samala N, et al
    Diagnostic value of serological scores for the detection of liver steatosis in people living with HIV in low- and middle-income countries.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004434.
    >> Share

  91. MURNANE PM, Bukusi EA, Otieno P, Frongillo EA, et al
    Effects of an agricultural intervention on psychosocial health among pregnant and non-pregnant women with HIV in Kenya.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004436.
    >> Share

  92. WILLIAMS A, Adungo F, Ramirez JL, Oriol-Mathieu V, et al
    The role of subtyping methodologies in HIV surveillance and vaccine development: a systematic review and meta-analysis.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004427.
    >> Share

  93. MARCELIN AG, Soulie C, Wirden M, Gruber J, et al
    Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens.
    AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004438.
    >> Share

  94. OMLAND LH, Senn A, Zutavern A, Orban M, et al
    Disability pension and sick leave in people with HIV compared with the background population - a nationwide population-based matched cohort study.
    AIDS. 2025 Dec 10. doi: 10.1097/QAD.0000000000004422.
    >> Share

  95. DE BEER ST, Phelanyane F, Ingle SM, Slogrove AL, et al
    Infectious-cause hospitalisation in a province-wide cohort of children with antenatal HIV exposure compared to children without HIV exposure.
    AIDS. 2025 Dec 10. doi: 10.1097/QAD.0000000000004423.
    >> Share

  96. LAM JO, Fan D, Pothamsetty N, Samiezade-Yazd Z, et al
    Dementia incidence and prevalence in older adults with HIV: A 23-year retrospective cohort study.
    AIDS. 2025 Dec 2. doi: 10.1097/QAD.0000000000004421.
    >> Share

  97. VELOSO M, Ribeiro M, Cabanas J, Goncalves F, et al
    Emerging patterns in HIV integrase resistance.
    AIDS. 2025;39:2324-2327.
    >> Share

  98. DE ARMAS LR, Tuyishime M, Justement JS, Jha S, et al
    Resistance to broadly neutralizing antibodies in perinatally infected infants from a Clade C HIV cohort in Mozambique.
    AIDS. 2025;39:2321-2324.
    >> Share

  99. NGHIEM VTH, Braithwaite RS
    COVID-19 as a natural experiment intervention to reduce new HIV infections among Australian MSM.
    AIDS. 2025;39:2319-2320.
    >> Share

  100. JEENA L, Kahari C, Ward KA, Gregson CL, et al
    The effects of HIV on bone and muscle health through the lifespan in populations living in Africa.
    AIDS. 2025;39:2161-2175.
    >> Share

  101. DHANJAL A, Shaw JG, Cole J, Green LR, et al
    Intersecting infections: the enhancing effect of Neisseria gonorrhoeae pathogenesis on HIV-1.
    AIDS. 2025;39:2151-2160.
    >> Share

  102. BRUMMEL SS, Swanson S, Caniglia E, Lockman S, et al
    A lesson in embracing uncertainty in early safety signals from the Tsepamo study.
    AIDS. 2025;39:2266-2273.
    >> Share

    November 2025
  103. YUAN R, Yan Y, Deng L, Li F, et al
    Risk factors of metabolic dysfunction-associated fatty liver disease in people living with HIV receiving antiretroviral therapy.
    AIDS. 2025 Nov 28. doi: 10.1097/QAD.0000000000004419.
    >> Share

  104. YADAV A, Stephens-Shields AJ, Karaj A, Kossenkov AV, et al
    Galantamine for 12 weeks does not improve neurocognition or immune activation in ART-suppressed people with HIV.
    AIDS. 2025 Nov 28. doi: 10.1097/QAD.0000000000004418.
    >> Share

  105. DAVEY CH, Dawson-Rose CS, Nokes KM, Corless IB, et al
    Sleep quality and disturbance during the COVID-19 pandemic among people with HIV globally: associations with social determinants of health.
    AIDS. 2025 Nov 28. doi: 10.1097/QAD.0000000000004417.
    >> Share

  106. ISMAIL A, Garba I, Muhammad AR, Dede H, et al
    Elevated cardiovascular risk in people living with HIV: the association with coronary artery calcification and endothelial dysfunction.
    AIDS. 2025 Nov 21. doi: 10.1097/QAD.0000000000004414.
    >> Share

  107. SADINSKI LM, Edwards JK, Herce ME, Avery CL, et al
    Blood pressure trajectories among people with and without HIV in a US-based prospective cohort study.
    AIDS. 2025 Nov 21. doi: 10.1097/QAD.0000000000004387.
    >> Share

  108. ZHU W, Huang YA, Patel RR, Kourtis AP, et al
    Suboptimal laboratory testing at PrEP initiation in the United States, 2022-2023.
    AIDS. 2025 Nov 21. doi: 10.1097/QAD.0000000000004413.
    >> Share

  109. ARMSTRONG E, Seo E, Boyachuk B, Loutfy M, et al
    Gut microbiome and healthy aging in HIV: data from the correlates of healthy aging in geriatric HIV (CHANGE HIV) cohort.
    AIDS. 2025 Nov 21. doi: 10.1097/QAD.0000000000004412.
    >> Share

  110. STEVENS O, Anderson RL, Sabin K, Garcia SA, et al
    HIV prevalence in transgender women and cisgender men who have sex with men in sub-Saharan Africa 2010-2022: a meta-analysis.
    AIDS. 2025 Nov 21. doi: 10.1097/QAD.0000000000004405.
    >> Share

  111. HAGE K, Carson J, Hosseini-Hooshyar S, Sacks-Davis R, et al
    Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studies.
    AIDS. 2025 Nov 17. doi: 10.1097/QAD.0000000000004408.
    >> Share

  112. BABU AM, Janzen D, Evans CD, Spence C, et al
    Antiretroviral utilization and adherence before versus after expansion of a provincial drug insurance policy.
    AIDS. 2025 Nov 17. doi: 10.1097/QAD.0000000000004409.
    >> Share

  113. GOHIL J, Mackie NE, Winston A
    The evolution of antiretroviral-associated drug-resistance mutations in an individual receiving dolutegravir/lamivudine.
    AIDS. 2025;39:2147-2149.
    >> Share

  114. APOLLO T, Yeo YR, Mugurungi OM, Sithole N, et al
    Case study of PEPFAR funding cuts on HIV infections and deaths: reversing hard-won gains.
    AIDS. 2025;39:2143-2146.
    >> Share

  115. ROBERTS ST, Browne EN, Moore E, Mungo J, et al
    Longer-acting preexposure prophylaxis product and delivery preferences among transgender women in the United States: a discrete choice experiment.
    AIDS. 2025;39:2140-2142.
    >> Share

  116. CLARK J, Caceres C
    Centering the voices of transwomen in HIV prevention.
    AIDS. 2025;39:2138-2139.
    >> Share

  117. GENER AR
    In lieu of an effective pan-viral curative treatment, does antiretroviral therapy help people clear non-HIV chronic infections?
    AIDS. 2025;39:2136-2137.
    >> Share

  118. DIB H, Nowak R, Niyongabo B
    Retention challenges and cost-effective strategies for anal precancer screening in HIV-positive individuals: preventing progression to anal cancer.
    AIDS. 2025;39:2133-2135.
    >> Share

  119. BISHOP MD, Xu L, Boyce CL, Drain PK, et al
    HIV-1 3? polypurine tract mutations and integrase inhibitor resistance.
    AIDS. 2025;39:1996-2013.
    >> Share

  120. FOSTER C
    Sexual and reproductive health issues facing young people with perinatal HIV infection.
    AIDS. 2025;39:1985-1995.
    >> Share

  121. TAHLIL KM, Pettifor AE, Edwards JK, Tang W, et al
    Uptake of facility-based HIV testing among adolescents and young adults in Nigeria.
    AIDS. 2025 Nov 12. doi: 10.1097/QAD.0000000000004393.
    >> Share

  122. KNIGHT J, Ma H, Sithole B, Khumalo L, et al
    Evaluating the impact of achieving cascade equality in Eswatini: a modelling study on the prevention impacts of antiretroviral therapy.
    AIDS. 2025 Nov 11. doi: 10.1097/QAD.0000000000004400.
    >> Share

  123. MALAMA K, Parker R, Wall KM, Kilembe W, et al
    HIV incidence and risk factors for seroconversion among female sex workers and single mothers in a 10-year prospective cohort.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004403.
    >> Share

  124. DIGGS MR, Chu SM, Fitch KV, Olefsky M, et al
    Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004401.
    >> Share

  125. ZHU X, Patel EU, Berry SA, Lucas GM, et al
    Hospital readmissions among adults with chronic kidney disease by HIV status in the United States.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004397.
    >> Share

  126. SHIINO T, Chikata T, Hayashida T, Tran LK, et al
    Epidemiological Links of HIV-1 CRF01_AE among Men Who Have Sex with Men in Northern Vietnam and Japan.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004406.
    >> Share

  127. OKHAGBUZO MI, Njuguna I, King'e M, Moraa H, et al
    Lower working memory and processing speed among children and youth exposed to HIV.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004402.
    >> Share

  128. LI QH, Zhao J, Hu SP, Wang FX, et al
    A novel second-generation HIV-1 circulating recombinant form (CRF183_0107) identified among men who have sex with men in China.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004404.
    >> Share

  129. SEWACK AB, Manning MR, Blazkova J, Justement JS, et al
    Correlations among quantitative assays that measure the size of HIV reservoirs in people with HIV receiving antiretroviral therapy.
    AIDS. 2025;39:1982-1984.
    >> Share

  130. BENZEKRI NA, Sambou JF, Diedhiou Y, Sagna ML, et al
    Partnering with traditional healers to increase HIV testing in Senegal, West Africa.
    AIDS. 2025;39:1978-1981.
    >> Share

  131. GHANOONI D, Heise MJ, Sassaman K, Glidden DV, et al
    Suboptimal ART adherence, undetectable urine tenofovir, and higher C-reactive protein values.
    AIDS. 2025;39:1975-1978.
    >> Share

  132. VERA JH, Martinez E
    Reassuring evidence on statins and cognition in people with HIV.
    AIDS. 2025;39:1970-1971.
    >> Share

  133. MOSEHOLM E, Omland LH, Katzenstein TL, Pedersen G, et al
    Retention in care and viral suppression in pregnant/postpartum vs. nonpregnant/nonpostpartum women with HIV.
    AIDS. 2025;39:1936-1945.
    >> Share

  134. MCHENRY MS, Masese ER, Kinyanjui D, Were E, et al
    Ethical considerations for research involving pregnant women with HIV and their children.
    AIDS. 2025;39:1866-1877.
    >> Share

  135. SMITH MR, Cai R, Cote HCF
    Off target effects of HIV integrase strand transfer inhibitors in cell and animal models: a scoping review.
    AIDS. 2025;39:1849-1865.
    >> Share

    October 2025
  136. KUCHUKHIDZE S, Kacanek D, Brummel SS, Davtyan M, et al
    Reproductive stage and other risk factors associated with intimate partner violence: a multi-site study of women living with HIV in the United States.
    AIDS. 2025 Oct 27. doi: 10.1097/QAD.0000000000004392.
    >> Share

  137. GRAETER A, Van Bibber N, Robertson J, Bowles K, et al
    Safety and efficacy of immune checkpoint inhibitors in persons living with HIV at a single, tertiary care cancer center in the US.
    AIDS. 2025 Oct 27. doi: 10.1097/QAD.0000000000004380.
    >> Share

  138. SCOTT J, Anglemyer A, Ong JJ, Kumbaroff Z, et al
    A systematic review of models used to estimate undiagnosed HIV prevalence in high income low prevalence countries and territories.
    AIDS. 2025 Oct 23. doi: 10.1097/QAD.0000000000004390.
    >> Share

  139. BUZON L, Bernardino JI, Galindo Puerto MJ, Martin-Torres J, et al
    Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.
    AIDS. 2025 Oct 23. doi: 10.1097/QAD.0000000000004388.
    >> Share

  140. BYRD KK, Tie Y, Lin CY, Kuo Y, et al
    Estimated major adverse cardiovascular events averted among persons with HIV if treated with a moderate-intensity statin.
    AIDS. 2025 Oct 16. doi: 10.1097/QAD.0000000000004385.
    >> Share

  141. KORPELA E, Dastgheyb RM, Letendre SL, Franklin DR Jr, et al
    Longitudinal effects of polypharmacy on cognitive function in people with HIV.
    AIDS. 2025 Oct 9. doi: 10.1097/QAD.0000000000004379.
    >> Share

  142. KIMMEL AD, Pan Z, Byrd KK, Stirratt M, et al
    Validity of competing algorithms to identify people with HIV in Medicaid administrative claims: a statewide analysis.
    AIDS. 2025 Oct 8. doi: 10.1097/QAD.0000000000004362.
    >> Share

  143. VOLLMOND CV, Tetens MM, Gerstoft J, Kronborg G, et al
    Risk of schizophrenia spectrum disorders among people with HIV: A nationwide, populationbased, matched cohort study.
    AIDS. 2025 Oct 8. doi: 10.1097/QAD.0000000000004373.
    >> Share

  144. DOGON C, Bengtson AM, Botha M, Burd T, et al
    Associations between maternal lipid profiles and cardiovascular and metabolic outcomes among children who are HIV-exposed uninfected versus HIV-unexposed children aged 5-8 years in a South African birth cohort.
    AIDS. 2025 Oct 8. doi: 10.1097/QAD.0000000000004377.
    >> Share

  145. ELIAS RH, Holtrop J, Smit C, Dorresteijn JAN, et al
    Estimated 10-year risk of recurrent cardiovascular events and potential health benefits of secondary prevention in people with HIV.
    AIDS. 2025 Oct 8. doi: 10.1097/QAD.0000000000004375.
    >> Share

  146. ABELMAN RA, Ma Y, Mehta CC, Yang Q, et al
    Menopause is associated with faster increases in insulin resistance in women with HIV.
    AIDS. 2025 Oct 8. doi: 10.1097/QAD.0000000000004378.
    >> Share

  147. HAGINS D, Berhe M, Crofoot GE, Ramgopal MN, et al
    Final efficacy and safety of twice-yearly subcutaneous lenacapavir in treatment-naive people with HIV: randomized study.
    AIDS. 2025 Oct 7. doi: 10.1097/QAD.0000000000004372.
    >> Share

  148. FAHEY CA, Ruderman SA, Drumright LN, Fredericksen RJ, et al
    Association between housing instability and frailty among people with HIV.
    AIDS. 2025 Oct 7. doi: 10.1097/QAD.0000000000004370.
    >> Share

  149. MOORE B, O'Connor S, Sato K, Briceno'Robaugh RI, et al
    Implementation of tuberculosis services for children living with HIV in PEPFAR-supported programs in 16 high TB/HIV-burden countries in sub-Saharan Africa, 2019-2022.
    AIDS. 2025 Oct 7. doi: 10.1097/QAD.0000000000004364.
    >> Share

  150. KNUDSEN AD, Gelpi M, Suarez-Zdunek MA, Loft JA, et al
    Inhibition of Th1-type immune responses in persons with HIV with current statin exposure.
    AIDS. 2025 Oct 7. doi: 10.1097/QAD.0000000000004366.
    >> Share

  151. HERNANDEZ-SANCHEZ D, Satorra P, Martinez A, Puig J, et al
    Muscular and plasma markers for early identification of frailty and sarcopenia states in people with HIV: results from the IMAGING study.
    AIDS. 2025 Oct 7. doi: 10.1097/QAD.0000000000004363.
    >> Share

  152. JAO J, Gochanour C, Williams PL, Schenkel S, et al
    Pubertal onset in children with in utero HIV/antiretroviral exposure in Botswana.
    AIDS. 2025 Oct 7. doi: 10.1097/QAD.0000000000004374.
    >> Share

  153. ELLIS RJ, Tang B, Heaton RK, Patel P, et al
    Predicting neurobehavioral outcomes in people with HIV.
    AIDS. 2025 Oct 7. doi: 10.1097/QAD.0000000000004365.
    >> Share

  154. VAN STEYN JT, Dear N, Esber A, Frndak S, et al
    A retrospective analysis of maternal factors, access of prevention of vertical transmission resources, and infant preterm delivery and mortality.
    AIDS. 2025 Oct 7. doi: 10.1097/QAD.0000000000004371.
    >> Share

  155. CARR A, Mngqibisa R, Khaertynova I, Kumar PN, et al
    Efficacy and safety of doravirine/islatravir in heavily treatment-experienced participants living with HIV-1 from a randomized trial.
    AIDS. 2025 Oct 2. doi: 10.1097/QAD.0000000000004367.
    >> Share

  156. GIULIANI M, Zaccarelli M, Stingone C, Gianserra L, et al
    The paradox of rising syphilis among MSM living with HIV amid declining HIV infections: a 33-year analysis.
    AIDS. 2025;39:1841-1844.
    >> Share

  157. GROENEWALD P, Glass T, Kallis N, Holmgren C, et al
    Under-reporting of HIV and AIDS as an underlying cause of death in South Africa.
    AIDS. 2025;39:1839-1841.
    >> Share

  158. SCHAEFER R, Lievense B, Day S, Donaldson L, et al
    Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention research.
    AIDS. 2025;39:1835-1838.
    >> Share

  159. LESKO CR, Marshall BDL
    The cost of defunding HIV surveillance systems in the United States.
    AIDS. 2025;39:1833-1834.
    >> Share

  160. VANCE DE, Layton S
    Posttraumatic stress disorder and Veterans with HIV: commentary on neurocognition, social cognition, and resilience.
    AIDS. 2025;39:1828-1830.
    >> Share

  161. MASENGA SK, Capeau J
    Myosteatosis in HIV: the adipose tissue connection.
    AIDS. 2025;39:1825-1827.
    >> Share

  162. ARENAS-PINTO A, Abrescia N, Abdel-Hameed EA
    Metabolic dysfunction-associated steatotic liver disease and liver fibrosis in people with HIV.
    AIDS. 2025;39:1822-1824.
    >> Share

  163. DAWOOD H
    The role of ECG in risk prediction for sudden cardiac and unexpected death in people with HIV.
    AIDS. 2025;39:1820-1821.
    >> Share

  164. VANCE DE, Lee J
    Social cognition abilities in people with HIV: the role of stigma and other factors.
    AIDS. 2025;39:1688-1698.
    >> Share

    September 2025
  165. MOUCHERAUD C, Trujillo D, Wagner Z, Garland W, et al
    Preferences for HIV prevention conditional cash transfers among Black/African American and Latinx cisgender MSM in Los Angeles.
    AIDS. 2025 Sep 26. doi: 10.1097/QAD.0000000000004361.
    >> Share

  166. ANDERSON K, Madlala HP, Nyemba DC, Dinkele R, et al
    Infectious morbidity among children HIV-exposed uninfected in South Africa: elevated risk in infancy but not thereafter.
    AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004358.
    >> Share

  167. NIKOLOVA KA, Moller DL, Loft JA, Suarez-Zdunek MA, et al
    Association of Cytomegalovirus Immunoglobulin G Antibodies with Prevalent and De Novo Hypertension in People With HIV.
    AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004355.
    >> Share

  168. FISHER MC, Scherzer R, Postalcioglu M, Chen TK, et al
    Associations of repeated measures of plasma biomarkers of kidney tubular health with longitudinal kidney function in people with HIV.
    AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004359.
    >> Share

  169. MARTIN-CARMONA J, Corona-Mata D, Tellez F, Navarrete Lorite MN, et al
    Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis.
    AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004357.
    >> Share

  170. VAN DEUZEN CM, Rijnders BJA, Bax HI, Rokx C, et al
    Cerebral toxoplasmosis in the twenty-first century: long-term clinical outcomes in a retrospective cohort study in the Netherlands.
    AIDS. 2025 Sep 23. doi: 10.1097/QAD.0000000000004356.
    >> Share

  171. MILIC J, Calza S, Lazzarini L, Cocchi M, et al
    Prevalence and risk factors of cognitive frailty in people with HIV.
    AIDS. 2025 Sep 19. doi: 10.1097/QAD.0000000000004352.
    >> Share

  172. DIETERICH DT, Brunet L, Hsu RK, Mounzer K, et al
    Tenofovir interruption among people with HIV and HBV: HBV monitoring and risk of HBV reactivation and hepatitis flare.
    AIDS. 2025 Sep 19. doi: 10.1097/QAD.0000000000004353.
    >> Share

  173. STOLTZ TT, Jensen AMR, Roed AKH, Frikke-Schmidt R, et al
    Plasma levels of lipoprotein(a) in persons with HIV compared to the general population.
    AIDS. 2025 Sep 19. doi: 10.1097/QAD.0000000000004349.
    >> Share

  174. STARKE SJ, He Z, Hollamby R, Moloantoa T, et al
    Advanced HIV disease and 30-day mortality among hospitalized adults with virally suppressed HIV in South Africa.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004336.
    >> Share

  175. WEI L, Tao C, Huang X, Wang RC, et al
    High triglyceride-glucose index is associated with diabetes mellitus in people with HIV in Southwest China: a 13-year retrospective longitudinal cohort study.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004342.
    >> Share

  176. NAIK V, Nekkalapudi A, Boopathy AV, Falkard B, et al
    Emergence of in vitro resistance to lenacapavir is similar across HIV-1 subtypes.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004334.
    >> Share

  177. FILIP I
    High body mass and depression accelerate physical decline in people with HIV - can exercise reverse the clock?
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004347.
    >> Share

  178. SUKUMARAN L, Dominguez-Dominguez L, Hamzah L, Liu J, et al
    Intersecting social determinants of health, multimorbidity and quality of life in people of Black ethnicities with HIV in South London: a mixed-methods study.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004343.
    >> Share

  179. NAVARRO-SOLER R, Martin-Torres J, Lagarde M, Bisbal O, et al
    Impact of antiretroviral regimens containing Integrase Inhibitors on achieving viral suppression at ultra-low levels compared to other ART strategies.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004340.
    >> Share

  180. CHANDRA A, Alt J, Dastgheyb RM, Veenhuis RT, et al
    Associations between cerebrospinal fluid N-acetyl-aspartyl-glutamate (NAAG) and cognitive function in people with HIV.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004341.
    >> Share

  181. COOLEY SA, Ferreiro A, Nelson B, Sukhum K, et al
    A randomized controlled trial to unveil the influence of an exercise intervention on brain integrity and gut microbiome structure in individuals with HIV.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004346.
    >> Share

  182. LIU Q, Jin L, Qing Y, Rang Z, et al
    Endoplasmic reticulum stress-induced goblet cell apoptosis might contribute to intestinal barrier damage in asymptomatic people living with HIV.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004335.
    >> Share

  183. WENG R, Kwon JA, Hammoud M, Clifton B, et al
    Evaluating the impact of COVID-19 on the HIV epidemic among men who have sex with men in Australia.
    AIDS. 2025 Sep 15. doi: 10.1097/QAD.0000000000004344.
    >> Share

  184. ASUPHON O, Boonpattharatthiti K, Rattanachaisit N, Wangteeraprasert A, et al
    Comparing clinical outcomes of antibiotics for treating mycobacterium avium complex infection in adults with HIV: a systematic review and network meta-analysis.
    AIDS. 2025 Sep 15. doi: 10.1097/QAD.0000000000004345.
    >> Share

  185. SOULIE C, Balde A, Fofana D, Charpentier C, et al
    No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people living with HIV.
    AIDS. 2025 Sep 8. doi: 10.1097/QAD.0000000000004339.
    >> Share

  186. ANNEQUIN M, Mora M, van Huizen R, Faye A, et al
    Structural factors associated with viral suppression among transgender women living with HIV in France.
    AIDS. 2025 Sep 8. doi: 10.1097/QAD.0000000000004337.
    >> Share

  187. PATEL N, Dulion B, Lazcano I, Shi Q, et al
    Antiretroviral-specific associations between bone hormonal changes and treatment induced weight gain.
    AIDS. 2025 Sep 4. doi: 10.1097/QAD.0000000000004330.
    >> Share

  188. SATRE DD, Sarovar V, Levine T, Alexeeff S, et al
    The relationship of smoking and unhealthy alcohol use to HIV care retention and viral suppression: findings from a multi-site cohort study.
    AIDS. 2025 Sep 4. doi: 10.1097/QAD.0000000000004329.
    >> Share

  189. DURSTENFELD MS, Nance RM, Jones R, Abelman R, et al
    Predicting risk of cardiovascular events (PREVENT) score accuracy among people with HIV in the multicenter CNICS cohort.
    AIDS. 2025 Sep 4. doi: 10.1097/QAD.0000000000004331.
    >> Share

  190. JEENA L, Ferrand RA, Simms V, Kahari C, et al
    Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe: Erratum.
    AIDS. 2025;39:1674-1675.
    >> Share

  191. ANTWI S, Yang H, Enimil A, Martyn-Dickens C, et al
    Tenofovir diphosphate concentrations in dried blood spots predict future HIV suppression but not virologic failure in adolescents with HIV.
    AIDS. 2025;39:1668-1671.
    >> Share

  192. ERLY S, Troupe D, Capizzi J, Amiya R, et al
    Increase in heterosexual transmission of HIV in international Pacific Northwest region (United States and Canada).
    AIDS. 2025;39:1666-1668.
    >> Share

  193. RAHIM FO, Nguyen NT, Chen JK, Mahatara EV, et al
    A rollback on PEPFAR will have far-reaching consequences in global health.
    AIDS. 2025;39:1663-1665.
    >> Share

  194. EGAN JE, Hillier SL, Avery AK, Friedman MR, et al
    The great mismatch: unfulfilled promise of biomedical HIV prevention.
    AIDS. 2025;39:1658-1660.
    >> Share

  195. BEYRER C, Ratevosian J, Gelderblom H, Rosenberg NE, et al
    The HIV/AIDS pandemic: where are we now?
    AIDS. 2025;39:1497-1504.
    >> Share

    August 2025
  196. KAMPHUIS AEM, Kiezebrink T, Waalewijn H, Bamford A, et al
    Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children living with HIV in the CHAPAS-4 trial.
    AIDS. 2025 Aug 26. doi: 10.1097/QAD.0000000000004328.
    >> Share

  197. ZHAO H, Ye S, Lang G, Tang D, et al
    Serum triglyceride and high-density lipoprotein at admission are associated with 30-day overall mortality of patients with HIV and Talaromycosis.
    AIDS. 2025 Aug 26. doi: 10.1097/QAD.0000000000004327.
    >> Share

  198. YU X, Carter M, Gao D, Nguyen N, et al
    Screening benefits for breast and colorectal cancer-specific survival among medicare enrollees with HIV.
    AIDS. 2025 Aug 19. doi: 10.1097/QAD.0000000000004325.
    >> Share

  199. HAN WM, Wu K, Tassiopoulos K, Knowles K, et al
    Inflammation in frailty, cognitive impairment, clinical events and mortality among older adults with HIV in the ACTG HAILO cohort.
    AIDS. 2025 Aug 14. doi: 10.1097/QAD.0000000000004324.
    >> Share

  200. INZAULE S, Silva R, Ford N, Thwin SS, et al
    Comparative analyses of COVID-19 in-hospital mortality in people living with HIV during SARS-CoV-2 pre-delta, delta, and omicron waves: data from the who global clinical platform.
    AIDS. 2025 Aug 14. doi: 10.1097/QAD.0000000000004323.
    >> Share

  201. CANIGLIA EC, Zash R, Diseko M, Mabuta J, et al
    Target trials of pre-conception switch from Nevirapine- or Efavirenz-based ART to dolutegravir-based ART on adverse birth and maternal outcomes.
    AIDS. 2025 Aug 13. doi: 10.1097/QAD.0000000000004321.
    >> Share

  202. MENDES DE LEON KF, Nieuwkerk PT, Lemkes BA, Geerlings SE, et al
    Preferences for long-acting treatment among people with HIV: a discrete choice experiment.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004314.
    >> Share

  203. IRIARTE E, Jones R, Wang CX, Hall CDX, et al
    Gait speed and neurocognition among older people with and without HIV.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004312.
    >> Share

  204. THOME B, Pacola DP, Negra MD, Durigon GS, et al
    Persistent immunological repercussions of late antiretroviral initiation in children living with HIV.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004311.
    >> Share

  205. MASCARELL P, Gutierrez-Ortiz de la Tabla A, Ledesma C, Fernandez-Gonzalez M, et al
    A decade of anal cancer screening in the context of HIV care: feasibility, acceptability, and long-term retention.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004313.
    >> Share

  206. D'AMICO R, Han K, Min S, Demoor R, et al
    Subcutaneous injections of cabotegravir + rilpivirine long-acting in virally suppressed adults with HIV-1.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004310.
    >> Share

  207. CALCAGNO A, Carola L, Barbara R, Marco M, et al
    Full reservoirs and poor adherence: two cases of symptomatic HIV cerebrospinal fluid escape with tenofovir alafenamide/emtricitabine/bictegravir.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004320.
    >> Share

  208. DAI M, Chander G, Webel AR, Delaney JA, et al
    Alcohol use disorder, but not current alcohol use is associated with falls among people with HIV in care.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004317.
    >> Share

  209. KARDASHIAN A, Golovaty I, Xia F, Ma Y, et al
    The association of food insecurity with hepatic steatosis in women with and without HIV.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004319.
    >> Share

  210. NIYONGABO B, Tuyishime S, Nkurikiyintwali JMV, Mfuranziza C, et al
    Effects of test-and-treat versus preexposure prophylaxis on elimination of HIV transmission: analysis of 24 HIV prevention trials.
    AIDS. 2025;39:1484-1485.
    >> Share

  211. KAMITANI E, Koenig LJ, Sullivan P
    Transformative potential of artificial intelligence in US CDC HIV interventions: balancing innovation with health privacy.
    AIDS. 2025;39:1311-1321.
    >> Share

    July 2025
  212. FILIP I
    As long-acting HIV prevention options gain momentum, the spotlight shifts to equitable access.
    AIDS. 2025 Jul 30. doi: 10.1097/QAD.0000000000004316.
    >> Share

  213. STEFFEN HM, Viola E, Thawani A, Kachere LG, et al
    Blood pressure, weight change and incident hypertension after switching to dolutegravir in treatment-experienced people living with HIV.
    AIDS. 2025 Jul 24. doi: 10.1097/QAD.0000000000004309.
    >> Share

  214. ERLANDSON KM, Umbleja T, Ribaudo HJ, Lu MT, et al
    No evidence of pitavastatin effect on muscle area or density among people with HIV.
    AIDS. 2025 Jul 22. doi: 10.1097/QAD.0000000000004306.
    >> Share

  215. MARCEAU T, Migraine J, Moreau A, Arrouche Y, et al
    Neutralizing antibodies and restriction factors cooperatively exert selective pressure on the HIV-1 envelope glycoprotein.
    AIDS. 2025 Jul 18. doi: 10.1097/QAD.0000000000004304.
    >> Share

  216. ROED AKH, Reimer Jensen AM, Knudsen AD, Gelpi M, et al
    Elevated high-sensitivity C-reactive protein and triglycerides in people with HIV treated with lipid-lowering therapy.
    AIDS. 2025 Jul 18. doi: 10.1097/QAD.0000000000004305.
    >> Share

  217. XUE K, Shi Y, Song F, Cai D, et al
    Glymphatic dysfunction in HIV: a resting-state fMRI biomarker linking cognitive impairment and immune suppression.
    AIDS. 2025 Jul 18. doi: 10.1097/QAD.0000000000004300.
    >> Share

  218. COGHILL AE, Thompson Z, Bamford L, Burkholder G, et al
    The association of immunosuppression and HIV control with Kaposi sarcoma among patients on antiretroviral therapy.
    AIDS. 2025 Jul 18. doi: 10.1097/QAD.0000000000004303.
    >> Share

  219. PINDER LF, Bertrand P, Fertitta V, Cahais V, et al
    Vaginal microbiome composition in women with HIV undergoing treatment of cervical transformation zone in a screen and treat program in Zambia.
    AIDS. 2025;39:1303-1306.
    >> Share

  220. SUZUKI K, Levert A, Yoo E, Cysique LA, et al
    Higher levels of cell-associated HIV-1 RNA transcripts predict risk of viral blips: implications for clinical management and cure research.
    AIDS. 2025;39:1300-1302.
    >> Share

  221. MASENGA SK, Anthony DD, Abdel-Hameed EA
    Microbial translocation and liver fibrosis in women with HIV - unraveling the gut-liver axis.
    AIDS. 2025;39:1297-1299.
    >> Share

  222. LUO G, Yan B, Shen Y
    The impact and mechanism of HIV infection on tuberculous granuloma formation.
    AIDS. 2025;39:1095-1105.
    >> Share

  223. FILIP I
    Evolving data on heart failure reshape prevention and treatment strategies for people with HIV.
    AIDS. 2025 Jul 15. doi: 10.1097/QAD.0000000000004299.
    >> Share

  224. ZHOU Q, Chen X, Shen W, Wang S, et al
    Risk factors of incident physical frailty in middle-aged and older people with and without HIV: evidence from the CHART cohort.
    AIDS. 2025 Jul 15. doi: 10.1097/QAD.0000000000004298.
    >> Share

  225. DARJI D, Norris S, Ohuma EO, Hemelaar J, et al
    Foetal growth in pregnant women with HIV: longitudinal analysis of serial ultrasound measurements in South Africa.
    AIDS. 2025 Jul 8. doi: 10.1097/QAD.0000000000004294.
    >> Share

  226. ZANG X, Sui Y, Bessey S, Van TM, et al
    On the compounding manifestations of racism shaping the US HIV/AIDS epidemic: Why Ending the HIV Epidemic must address these factors for success.
    AIDS. 2025 Jul 7. doi: 10.1097/QAD.0000000000004289.
    >> Share

  227. WIJSTMA ES, Jongen VW, Boyd A, De Vries HJC, et al
    Subpopulations with frequent healthcare barriers have increased risk of sexually transmitted infections and dropping out from HIV pre-exposure prophylaxis care.
    AIDS. 2025 Jul 2. doi: 10.1097/QAD.0000000000004224.
    >> Share

  228. HWANG YJ, Lesko CR, Brown TT, Alexander GC, et al
    Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV: Erratum.
    AIDS. 2025;39:1094.
    >> Share

  229. YADAV A, Gionet G, Karaj A, Kossenkov AV, et al
    Association of smoking with neurocognition, inflammatory and myeloid cell activation profiles in people with HIV on antiretroviral therapy: Erratum.
    AIDS. 2025;39:1093.
    >> Share

  230. OTTO M, Okango E, Mee P, Dobra A, et al
    Trends in population HIV viral suppression: a longitudinal analysis.
    AIDS. 2025;39:1088-1092.
    >> Share

  231. PREVEDEN A, Garipi E, Bogdan M, Preveden M, et al
    Influence of disturbed blood flow on endothelial function in people with HIV.
    AIDS. 2025;39:1086-1088.
    >> Share

  232. TINCATI C, Fusco FM, Santoro A, de Iaco F, et al
    HIV screening in the emergency department: an opinion piece by the Italian Societies of Infectious Diseases and Emergency Medicine.
    AIDS. 2025;39:927-934.
    >> Share

    June 2025
  233. MARCUS ME, Zang E, Hove J, Jordan H, et al
    Left behind? A longitudinal analysis of need for PrEP services among middle-aged and older adults in South Africa.
    AIDS. 2025 Jun 27. doi: 10.1097/QAD.0000000000004283.
    >> Share

  234. HOPWOOD-RAJA JJ, Tseng AL, Sheehan NL, Walmsley SL, et al
    CHANGE-Rx: frailty, falls, polypharmacy, and inappropriate medication use in a canadian cohort of people aged 65 and older living with HIV.
    AIDS. 2025 Jun 27. doi: 10.1097/QAD.0000000000004284.
    >> Share

  235. MEYER-RATH G, Jamieson L, Mudimu E, Imai-Eaton JW, et al
    The cost of the plunge: The impact and cost of a cessation of PEPFAR-supported services in South Africa.
    AIDS. 2025 Jun 23. doi: 10.1097/QAD.0000000000004272.
    >> Share

  236. BUCKLEY J, Cassim H, Otwombe K, Hlongwane K, et al
    Neurocognitive functioning in women living with HIV: A comparative study in a Low/Middle-income Country.
    AIDS. 2025 Jun 23. doi: 10.1097/QAD.0000000000004277.
    >> Share

  237. CHOW D, Pronyk P, Mgimba R, Elimwaria W, et al
    Integrating a mental health referral system within adolescent HIV clinics in Tanzania.
    AIDS. 2025 Jun 19. doi: 10.1097/QAD.0000000000004279.
    >> Share

  238. VO AT, Wynn A, Hernandez M, Terris-Prestholt F, et al
    Unit Costs of Opioid Agonist Therapy (OAT): A Global Systematic review and cost Extrapolation.
    AIDS. 2025 Jun 13. doi: 10.1097/QAD.0000000000004263.
    >> Share

  239. AYER A, Mukondwa RW, Aviles Guaman C, Takarinda K, et al
    Poverty and protection: the relationship between multidimensional poverty, social protections interventions, and HIV viral load.
    AIDS. 2025 Jun 13. doi: 10.1097/QAD.0000000000004276.
    >> Share

  240. ERLANDSON KM, McKhann A, Kitch DW, Palella FJ, et al
    No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV.
    AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004267.
    >> Share

  241. GRIFFITHS PM, Samra R, Lester G, Rawson-Harris P, et al
    Cervical cancer screening in women living with HIV: an audit of clinical care.
    AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004266.
    >> Share

  242. ZHAO OS, Silver HJ, Fan R, Ye F, et al
    Subcutaneous adipose tissue gene transcripts associated with progressive myosteatosis in persons with HIV.
    AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004264.
    >> Share

  243. HAGE K, Boyd A, Davidovich U, Generaal E, et al
    The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the pre-randomization phase of a clinical trial.
    AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004265.
    >> Share

  244. BEDDEK K, Boufassa F, Mouanga C, Bitu M, et al
    Higher plasma concentrations of von Willebrand factor in women than in men during both the acute and chronic phases of HIV infection.
    AIDS. 2025 Jun 10. doi: 10.1097/QAD.0000000000004253.
    >> Share

  245. SUKUMARAN L, Winston A, Post FA, Anderson J, et al
    Changes in multimorbidity burden and their impact on patient and healthcare outcomes in people with HIV over a 3-5-year period.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004260.
    >> Share

  246. BAUGHER AR, Wejnert C, Kanny D, Broz D, et al
    Are we ending the HIV epidemic among persons who inject drugs?: Key findings from 19 U.S. cities, 2022.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004249.
    >> Share

  247. MAGUT F, Mazibuko L, Mthiyane N, Harling G, et al
    Hiv and herpes simplex virus 2 incidence among adolescent girls and young women who sell sex (YWSS) in rural south africa: a population-based cohort study.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004255.
    >> Share

  248. FITTIPALDI J, Cardoso SW, Nunes EP, De Almeida CF, et al
    Metabolic dysfunction-associated steatotic liver disease (MASLD) was associated with liver fibrosis in people living with HIV from Brazil.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004250.
    >> Share

  249. KOETHE JR, Robles ME, Widmer A, Lillegard K, et al
    Lower skeletal muscle density on CT imaging is associated with incomplete fatty acid oxidation, as measured by plasma acylcarnitines, in men with HIV.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004258.
    >> Share

  250. MATA MARIN JA, Rodriguez Evaristo MS, Cano Diaz AL, Salinas Velazquez GE, et al
    Incidence of Metabolic syndrome in people with HIV without experienCe to antiretroviral Therapy who start doLutegravir based-regimen compared with bictegrAvir based-regimeN after 48 weeks (MICTLAN trial).
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004259.
    >> Share

  251. MERAD Y, Mariaggi AA, Karmochkine M, Slama L, et al
    Virological success despite archived INSTI drug resistance mutations on INSTI-based antiretroviral regimens.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004251.
    >> Share

  252. WALPERT AR, Gupta M, Dunderdale CN, Haptu HH, et al
    Exploring the PREVENT HF score and myocardial function among persons with HIV.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004252.
    >> Share

  253. BERNAL E, Martinez-Rodriguez R, Gomez JM, Tomas C, et al
    Low-level viremia linked to virological failure but not clinical events: a competing risks study.
    AIDS. 2025 Jun 3. doi: 10.1097/QAD.0000000000004248.
    >> Share

  254. LOABILE B, Bilker WB, Khunou K, Ngwako N, et al
    Association of HIV status with infections complicating abortion in Botswana.
    AIDS. 2025;39:923-926.
    >> Share

  255. MAROZIN S, Bono V, Mazzoccoli M, Augello M, et al
    Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection.
    AIDS. 2025;39:921-923.
    >> Share

  256. VAN DE PERRE P, Moore PL, Nagot N, Gama L, et al
    Broadly neutralizing antibodies, nonneutralizing antibodies and broadly effector antibodies to prevent HIV transmission?
    AIDS. 2025;39:918-920.
    >> Share

  257. FILIP I
    Will long-acting HIV preexposure prophylaxis live up to its promise?
    AIDS. 2025;39:N11-N12.
    >> Share

    May 2025
  258. YAP SH, Hisham S, Ho WY, Hor WBW, et al
    Cross sectional analysis of factors associated with low intrinsic capacity among Malaysians ageing with HIV in ambulatory care.
    AIDS. 2025 May 23. doi: 10.1097/QAD.0000000000004246.
    >> Share

  259. DEFILIPPI C, Awwad A, Bloomfield GS, Weir IR, et al
    Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial.
    AIDS. 2025 May 23. doi: 10.1097/QAD.0000000000004243.
    >> Share

  260. ROBERTS ST, Browne EN, Denson D, Moore E, et al
    Longer-acting pre-exposure prophylaxis product and delivery preferences among U.S. populations disproportionately affected by HIV: a discrete choice experiment.
    AIDS. 2025 May 23. doi: 10.1097/QAD.0000000000004247.
    >> Share

  261. VYAS KJ, Marconi VC, Agan BK, Sullivan PS, et al
    Posttraumatic stress disorder and its associations with morbidity and mortality among veterans with HIV.
    AIDS. 2025 May 22. doi: 10.1097/QAD.0000000000004241.
    >> Share

  262. WANG D, Michel KG, Umans JG, Dalby S, et al
    Fetoplacental arteriolar dysfunction in placentas of HIV-exposed, small for gestational age birthweight neonates.
    AIDS. 2025 May 22. doi: 10.1097/QAD.0000000000004242.
    >> Share

  263. DING Y, Li J, Gao C, Xing L, et al
    Machine learning algorithms to predict the risk of hyperlipidemia in people living with HIV after starting HAART for 6 months.
    AIDS. 2025 May 21. doi: 10.1097/QAD.0000000000004244.
    >> Share

  264. THITIPATARAKORN S, Teeratakulpisarn N, Nonenoy S, Klinsukontakul A, et al
    The natural history of anal high-grade squamous intraepithelial lesions among men who have sex with men and transgender women in an acute HIV cohort in Thailand.
    AIDS. 2025 May 19. doi: 10.1097/QAD.0000000000004238.
    >> Share

  265. MORAKA NO, Ralegoreng C, Lemogang GM, Makwakwa R, et al
    HIV-1 infection recency among individuals newly diagnosed with HIV in Greater Gaborone, Botswana.
    AIDS. 2025 May 19. doi: 10.1097/QAD.0000000000004239.
    >> Share

  266. NICASTRO TM, Mocello AR, Weke E, Bukusi EA, et al
    Effect of a climate-smart intervention on agriculture and nutrition of people with HIV: a cluster-randomized trial.
    AIDS. 2025 May 15. doi: 10.1097/QAD.0000000000004234.
    >> Share

  267. HAMILTON DT, Hoover KW, Delaney KP
    Reducing HIV incidence in the southern US through routine opt-out HIV screening.
    AIDS. 2025 May 15. doi: 10.1097/QAD.0000000000004237.
    >> Share

  268. APPLETON AA, Lee S, Kuniholm MH, Vasquez E, et al
    Adverse childhood experiences, sexual orientation-related victimization, and cardiovascular disease risk among men living with and without HIV.
    AIDS. 2025 May 15. doi: 10.1097/QAD.0000000000004235.
    >> Share

  269. JIA C, Peters BA, Usyk M, Wang Z, et al
    Associations of fecal and blood microbiota-related metabolites with gut microbiota and type 2 diabetes in HIV infection.
    AIDS. 2025 May 6. doi: 10.1097/QAD.0000000000004231.
    >> Share

  270. GARRATT A, Muraleetharan A, Fairhead C, Hill A, et al
    Effects of Test-and-Treat versus PrEP on elimination of HIV transmission: analysis of 24 HIV prevention trials.
    AIDS. 2025 May 5. doi: 10.1097/QAD.0000000000004232.
    >> Share

  271. MEZZADRI L, Soria AG, Ranzani A, Malandrin S, et al
    Hepatitis B core antibody positivity is not associated with risk of transaminase elevation following switch to dual antiretroviral therapy.
    AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004227.
    >> Share

  272. DOS SANTOS AP, Willig AL, Ruderman SA, Oliveira VHF, et al
    The lipid research clinics physical activity questionnaire does not accurately measure physical activity in people with HIV.
    AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004226.
    >> Share

  273. CLEMENTE T, Bellomo M, Raccagni AR, Lolatto R, et al
    Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIV.
    AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004225.
    >> Share

  274. MATARAMVURA H, Jordan-Paiz A, Naidoo K, Jaeger J, et al
    Altered mitochondrial mass and fatty acid uptake by NK cells in HIV-exposed uninfected children at 6 years of age.
    AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004228.
    >> Share

  275. ABDALLA S, Compagnucci A, Bamford A, Chan MK, et al
    Assessment of the steady-state drug-drug interactions between dolutegravir and ritonavir-boosted darunavir in adolescents.
    AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004223.
    >> Share

  276. BUSZA J, Machingura F, Kujeke T, Makamba M, et al
    What happened with preexposure prophylaxis uptake among female sex workers in Zimbabwe? Implications for future prevention programmes.
    AIDS. 2025;39:771-773.
    >> Share

  277. HATCHER AM, Metheny N, Dunkle KL, Fielding-Miller R, et al
    A refusal to abandon HIV science.
    AIDS. 2025;39:768-770.
    >> Share

  278. MELDRUM BG, McGee-Avila JK, Luo Q, Milan J Jr, et al
    Racial disparities in cancer risk among MSM with HIV in the United States.
    AIDS. 2025;39:728-736.
    >> Share

  279. PARCZEWSKI M, Boesecke C, Khaykin P, Jilich D, et al
    Provision of care for people with HIV migrating from Ukraine: preparing for a long-term response.
    AIDS. 2025;39:629-638.
    >> Share

    April 2025
  280. WATI DK, Nguyen LV, Quy DT, Nguyen DQ, et al
    Outcomes of children living with HIV during the COVID-19 pandemic in Vietnam.
    AIDS. 2025 Apr 24. doi: 10.1097/QAD.0000000000004222.
    >> Share

  281. FILIP I
    Inflammation and silent myocardial damage may play a key role in predicting cardiovascular risk for people with HIV.
    AIDS. 2025 Apr 24. doi: 10.1097/QAD.0000000000004211.
    >> Share

  282. ZHANG R, Chung SL, Lee SS, Wong NS, et al
    Prevalence and resistance patterns of Mycoplasma genitalium infection in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004219.
    >> Share

  283. TENKORANG EY
    The health impact of spiritual intimate partner abuse among women living with HIV in Ghana.
    AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004221.
    >> Share

  284. HILL A, Fairhead C, Manalu S, Venter F, et al
    Could reduced dosing maintain more people on antiretrovirals after the sudden cuts in USAID funding? A crisis response.
    AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004212.
    >> Share

  285. HEJBLUM G, Daher S, Moulaire P, Amat K, et al
    Cost-effectiveness of a 4 days-a-week triple therapy in persons living with HIV: an ancillary study of the QUATUOR trial.
    AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004215.
    >> Share

  286. BUCHWALD AG, Crespo-Llado MM, Maliwichi L, Mdhluli C, et al
    The effect of environment and in utero HIV exposure on neurodevelopment in infants.
    AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004217.
    >> Share

  287. ELLIS J, Dai B, Kabahubya M, Hale G, et al
    Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease: a prospective cohort study.
    AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004213.
    >> Share

  288. YANG X, Chen X, Shen W, Wang S, et al
    Post antiretroviral treatment dynamics of blood EBV DNA among people with HIV: A prospective cohort study.
    AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004214.
    >> Share

  289. OH TK, Song KH, Heo E, Song IA, et al
    Association between HIV and cancer risk: a nationwide, population-based cohort study.
    AIDS. 2025 Apr 15. doi: 10.1097/QAD.0000000000004210.
    >> Share

  290. NAMPOTA-NKOMBA N, Mohanty K, Adebiyi R, Ekeh C, et al
    Penile human papillomavirus prevalence in circumcised sexual minority men living with and without HIV.
    AIDS. 2025 Apr 15. doi: 10.1097/QAD.0000000000004209.
    >> Share

  291. BOUWMEESTER TA, van der Wulp IAJ, Kusi Mensah YA, Wit FWNM, et al
    Impaired autonomic cardiovascular control in people with HIV on long-term successful treatment.
    AIDS. 2025 Apr 10. doi: 10.1097/QAD.0000000000004208.
    >> Share

  292. DUARTE HA, Birnbaum JK, Carlucci JG, Ghazal Y, et al
    Modeling the potential impact of viral load monitoring on vertical transmission of HIV in Kenya.
    AIDS. 2025 Apr 10. doi: 10.1097/QAD.0000000000004207.
    >> Share

  293. LI Y, Soto-Ramirez ZN, Roscher J, Medvec T, et al
    Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence.
    AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004204.
    >> Share

  294. VAN DER MANNEN JS, Furamera S, Pienaar J, Komane P, et al
    Predictors of unsuppressed viral load among men who have sex with men living with HIV in South Africa.
    AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004205.
    >> Share

  295. WANG L, Li SM, Li X, Wu HS, et al
    The transmembrane nucleoporin Nup210 weakens HIV-1 infection via modulating late events of viral nuclear import.
    AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004206.
    >> Share

  296. GLENN JS, Bennett A, Mackie N, Lyall H, et al
    The cumulative prevalence of HIV-1 drug resistance in perinatal HIV.
    AIDS. 2025 Apr 4. doi: 10.1097/QAD.0000000000004202.
    >> Share

  297. ADAMSON PC, Bui HTM, Pham LQ, Truong PT, et al
    Routine testing for chlamydia and gonorrhea in an HIV Pre-Exposure prophylaxis program in hanoi, vietnam: implications for low- and middle-income countries.
    AIDS. 2025 Apr 4. doi: 10.1097/QAD.0000000000004203.
    >> Share

  298. BENZEKRI NA, Plaisy MK, Koffi JJ, Mensah E, et al
    Food insecurity and mental health outcomes among people living with HIV in West Africa.
    AIDS. 2025 Apr 3. doi: 10.1097/QAD.0000000000004200.
    >> Share

  299. MOLLAN KR, Pence BW, Westreich D, Bula A, et al
    Effectiveness of levonorgestrel implant and depot medroxyprogesterone acetate injectable for women living with HIV on efavirenz: a prospective cohort study.
    AIDS. 2025 Apr 3. doi: 10.1097/QAD.0000000000004201.
    >> Share

  300. SHAH S, Short CE, Taylor G, Lyall H, et al
    Comparison of pregnancy outcomes between people with perinatally acquired HIV, horizontally acquired HIV and those without HIV.
    AIDS. 2025;39:621-624.
    >> Share

  301. RAMASWAMI R, Kelesidis T, Goedert JJ
    When cytokine storms collide: understanding hemophagocytic lymphohistiocytosis in human herpesvirus 8/Kaposi sarcoma herpesvirus-associated multicentric Castleman disease among people with HIV.
    AIDS. 2025;39:618-620.
    >> Share

  302. SAMAHA J, Madhu S, Shehadeh LA, Martinez CA, et al
    Osteopontin as a potential mediator of inflammation in HIV and comorbid conditions.
    AIDS. 2025;39:483-495.
    >> Share

  303. RIOS-VAZQUEZ V, Vos WAJW, Blaauw MJT, Van Eekeren LE, et al
    Dolutegravir plus lamivudine downregulates cellular stress responses versus three-drug HIV Regimens.
    AIDS. 2025 Apr 1. doi: 10.1097/QAD.0000000000004198.
    >> Share

  304. YANG GW, Zhou QW, Zhen X, Yang Y, et al
    A promising prognostic model for patients with AIDS-related lymphoma in the cART era.
    AIDS. 2025 Apr 1. doi: 10.1097/QAD.0000000000004197.
    >> Share

    March 2025
  305. LIN LY, Ferte T, Chachage M, Casteano C, et al
    Deciphering HIV vaccine-induced Antibody response according to ethnicity.
    AIDS. 2025 Mar 31. doi: 10.1097/QAD.0000000000004196.
    >> Share

  306. KAMITANI E, DeLuca JB, Mizuno Y
    Systematic review of infodemiology studies using artificial intelligence: social media posts on HIV pre-exposure prophylaxis.
    AIDS. 2025 Mar 27. doi: 10.1097/QAD.0000000000004193.
    >> Share

  307. MARTINSON T, Heise MJ, Sassaman K, Schmidt HR, et al
    Interest and disparities in awareness and uptake of doxyPEP among U.S. MSM living with HIV.
    AIDS. 2025 Mar 27. doi: 10.1097/QAD.0000000000004192.
    >> Share

  308. DUARTE MJ, Tien PC, Kardashian A, Ma Y, et al
    Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV.
    AIDS. 2025 Mar 25. doi: 10.1097/QAD.0000000000004189.
    >> Share

  309. ZHANG L, Chen N, Wang X, Du J, et al
    Increased frequency of Foxp3+CD8+ T cells are associated with disease progression during HIV infection.
    AIDS. 2025 Mar 20. doi: 10.1097/QAD.0000000000004185.
    >> Share

  310. REIS K, Stephano PF, Fadhil S, Willkens M, et al
    Arterial stiffness in people with HIV: a cross-sectional, comparative study with echocardiographic outcomes in Tanzania.
    AIDS. 2025 Mar 20. doi: 10.1097/QAD.0000000000004184.
    >> Share

  311. ANDERSON K, Eley BS, Rabie H, Muloiwa R, et al
    Hospitalisation incidence among young children living with HIV in the Western Cape, South Africa.
    AIDS. 2025 Mar 18. doi: 10.1097/QAD.0000000000004156.
    >> Share

  312. BEYDOUN N, Nance RM, Durstenfeld MS, Hoffmann AP, et al
    Multicenter study of heart failure phenotypes and physician-adjudicated etiologies in people with HIV.
    AIDS. 2025 Mar 18. doi: 10.1097/QAD.0000000000004182.
    >> Share

  313. SORENSEN EF, Hybel TE, Ludvigsen M
    Response to correspondence piece on 'Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes'.
    AIDS. 2025;39:481.
    >> Share

  314. DAUNGSUPAWONG H, Wiwanitkit V
    Characterization of the genomic landscape of HIV-associated lymphoma.
    AIDS. 2025;39:480.
    >> Share

  315. BELLOMO M, Gianotti N, Hasson H, Canetti D, et al
    Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimens.
    AIDS. 2025;39:477-479.
    >> Share

  316. MUCCINI C, Spagnuolo V, Zazzi M, Castagna A, et al
    People with four-class drug-resistant HIV-1 may have low levels of intact DNA.
    AIDS. 2025;39:475-476.
    >> Share

  317. BABALOLA CM, Peters RPH, Muzny CA, Davey DJ, et al
    From pregnancy to beyond: renewed emphasis on comprehensive HIV prevention in South Africa.
    AIDS. 2025;39:470-474.
    >> Share

  318. GOODKIN K
    Sleep in the context of neuropsychiatric and primary medical comorbidity patterns among people with HIV.
    AIDS. 2025;39:467-469.
    >> Share

  319. COHN SE
    Women with HIV: increased need for reproductive health services to improve health outcomes.
    AIDS. 2025;39:464-466.
    >> Share

  320. BARBER TJ, Gonzalez-Scarano F, Vance DE
    Cognitive dysfunction in people with HIV: the potential effect of personal and environmental circumstances.
    AIDS. 2025;39:462-463.
    >> Share

  321. SHORT WR, Rakhmanina N
    Expanding choices of antiretroviral treatment regimens for pregnant and breastfeeding persons with HIV.
    AIDS. 2025;39:459-461.
    >> Share

  322. KUHN L, Thomas P
    Studies of young adults with perinatal HIV infection provide new clues for HIV cure.
    AIDS. 2025;39:457-458.
    >> Share

  323. LUCEY M, Burns F, Bhagani S, Lipman M, et al
    SARS-CoV-2 antibody prevalence in adults living with HIV.
    AIDS. 2025 Mar 13. doi: 10.1097/QAD.0000000000004180.
    >> Share

  324. KONSTANTINIDIS I, Papageorgiou SN, Zou RH, Ronit A, et al
    Effect of HIV on respiratory symptoms, health status, and exertional capacity: a systematic review and meta-analysis.
    AIDS. 2025 Mar 13. doi: 10.1097/QAD.0000000000004179.
    >> Share

  325. DAO TTD, Filipowicz TR, Edmonds A, Ramirez C, et al
    Depressive symptoms among women of reproductive age with and without HIV in the Southern United States: baseline description from the STAR cohort.
    AIDS. 2025 Mar 13. doi: 10.1097/QAD.0000000000004181.
    >> Share

  326. IZQUIERDO R, Rava M, Gutierrez F, Garcia-Fraile LJ, et al
    Increased mortality and morbidity risk in people with early HIV care interruption in Spain, 2004-2023.
    AIDS. 2025 Mar 10. doi: 10.1097/QAD.0000000000004175.
    >> Share

  327. MAZZITELLI M, Krankowska D, Cozzolino C, Scaglione V, et al
    Sexual health knowledge, interest and acceptability of PrEP in migrant women: the MIMOSA study.
    AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004174.
    >> Share

  328. LIEBZEIT CJ, Deng HY, Liang B, Li L, et al
    Unique expression of genes influencing transendothelial leukocyte migration in HIV-1 resistant women in the pumwani sex worker cohort.
    AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004177.
    >> Share

  329. SCHMIDT HR, Heise MJ, Sassaman K, D'Angelo A, et al
    High viral suppression amid demographic disparities: a U.S. national cohort of people with HIV on a popular dating app.
    AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004173.
    >> Share

  330. INZAULE S, Jordan MR, Fokam J, Hamers RL, et al
    Non-canonical HIV drug resistance mutations: need to close existing gaps.
    AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004170.
    >> Share

  331. MUNK K, Suarez-Zdunek MA, Krabek R, Hamm SR, et al
    Association between low skeletal muscle mass and lung function decline in people with HIV: a prospective cohort study.
    AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004172.
    >> Share

  332. JORDANS CCE, Vliegenthart-Jongbloed K, Osbak KK, Hanssen JLJ, et al
    Implementing HIV teams sustainably improves HIV indicator condition testing rates in hospitals in the Netherlands: the #aware.hiv clinical trial.
    AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004167.
    >> Share

  333. PIGGOTT DA, Mehta SH, Rubin LH, Sun J, et al
    Cognitive function and mortality among persons aging with HIV and injection drug use.
    AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004169.
    >> Share

  334. OLIVEIRA VH, Willig AL, Davey CH, Buford TW, et al
    Abdominal adiposity is negatively associated with physical function among people with HIV.
    AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004168.
    >> Share

  335. MOYLE G, Gruber J, Dunbar M, Radtchenko J, et al
    Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruption.
    AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004171.
    >> Share

  336. CASPER SJ, Fix ML, Spivak AM
    A blind spot in HIV diagnosis guidelines?
    AIDS. 2025;39:334-335.
    >> Share

  337. ZHEN XM, Liu ZH, Zhang L, Xiao F, et al
    Epstein-Barr virus-associated smooth muscle tumor with multiple lesions in a patient with AIDS.
    AIDS. 2025;39:330-333.
    >> Share

  338. MARZIALI ME, Kooij KW, Zhang W, Budu M, et al
    Fatal overdoses among people with HIV experiencing nonfatal overdoses in British Columbia, Canada.
    AIDS. 2025;39:328-330.
    >> Share

  339. TAO J, Maguire-Wilkerson A, Rusley J, Wray T, et al
    Implementing conversational artificial intelligence technology for the prevention of HIV and other sexually transmitted infections in real-world settings.
    AIDS. 2025;39:324-327.
    >> Share

  340. GOODKIN K, Pollack HA
    Contextual factors related to the overlap of the overdose and HIV pandemics and their clinical implications.
    AIDS. 2025;39:321-323.
    >> Share

  341. NGENO GTK, Bloomfield GS
    Global health solidarity in the HIV and hypertension disease response.
    AIDS. 2025;39:319-320.
    >> Share

  342. BRENNER BG, Fairlie L
    The need to avert emergent resistance to dolutegravir in children and adolescents with HIV.
    AIDS. 2025;39:317-318.
    >> Share

  343. BENNETT T, Walmsley S, Bendayan R
    Aging with HIV and HIV-associated neurocognitive impairment.
    AIDS. 2025;39:215-228.
    >> Share

    February 2025
  344. NAJJUUKO C, Brathwaite R, Xu Z, Kizito S, et al
    Using machine learning to predict poor adherence to antiretroviral therapy among adolescents living with HIV in low resource settings.
    AIDS. 2025 Feb 25. doi: 10.1097/QAD.0000000000004163.
    >> Share

  345. WHELTON SP, Haberlen SA, Zhang L, Herrschaft R, et al
    Associations between HIV serostatus and coronary artery plaque volume progression.
    AIDS. 2025 Feb 25. doi: 10.1097/QAD.0000000000004165.
    >> Share

  346. TAM C, Zhang W, Moore D, Salters K, et al
    Impacts of overdose and socio-structural factors on recent mortality among people living with HIV in British Columbia, Canada.
    AIDS. 2025 Feb 24. doi: 10.1097/QAD.0000000000004158.
    >> Share

  347. CHALOUNI M, Van Santen DK, Berenguer J, Jarrin I, et al
    Time to direct-acting antivirals initiation and liver-related events in people with HIV and Hepatitis C virus.
    AIDS. 2025 Feb 19. doi: 10.1097/QAD.0000000000004161.
    >> Share

  348. LI W, Egler A, Oyungu E, Yang Z, et al
    Pro- and anti-inflammatory immune biomarkers as predictors of neurodevelopment in young children exposed to HIV.
    AIDS. 2025 Feb 19. doi: 10.1097/QAD.0000000000004162.
    >> Share

  349. NUHN MM, Bosman K, Huisman T, Staring WHA, et al
    Selective decline of intact HIV reservoirs during the first decade of ART followed by stabilization in memory T cell subsets.
    AIDS. 2025 Feb 17. doi: 10.1097/QAD.0000000000004160.
    >> Share

  350. VAN PAASSEN PM, Boyd AC, Pasternak AO, Maurer I, et al
    Soluble CD14 and IL-12p70 on early ART predict HIV load setpoint after treatment interruption.
    AIDS. 2025 Feb 14. doi: 10.1097/QAD.0000000000004159.
    >> Share

  351. FILIP I
    Transplantation of kidneys from donors with HIV: are we there yet?
    AIDS. 2025 Feb 13. doi: 10.1097/QAD.0000000000004155.
    >> Share

  352. SHEIRA LA, Kwena ZA, Ayieko B, Charlebois ED, et al
    The effect of a social network-based intervention on adherence to HIV pre-exposure prophylaxis and HIV viral suppression among Kenyan fishermen.
    AIDS. 2025 Feb 13. doi: 10.1097/QAD.0000000000004157.
    >> Share

  353. RAMI A, Pozniak AL, Assoumou L, Movahedi R, et al
    Use of doravirine-based regimens in clinical practice in Europe: a real-life retrospective observational study.
    AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004151.
    >> Share

  354. HERLIHY JM, Zulu E, Mwananyanda L, Forman L, et al
    Risk of hospitalization or death does not differ in children exposed to HIV, yet uninfected compared to non-exposed peers in the Zambia Infant Cohort Study (ZICS).
    AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004152.
    >> Share

  355. BALDIN G, Salvo PF, Passerotto RA, Iannone V, et al
    'With age comes wisdom': effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV.
    AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004153.
    >> Share

  356. VOLESKY-AVELLANEDA KD, Luo Q, Amaswami RR, Lurain K, et al
    Primary effusion lymphoma in people with and without HIV infection in the United States.
    AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004154.
    >> Share

  357. AGBEY C, Walton S, Campbell LA, Nath A, et al
    Expression of human immunodeficiency virus envelope protein in the human central nervous system.
    AIDS. 2025 Feb 11. doi: 10.1097/QAD.0000000000004150.
    >> Share

  358. MATOVU KIWEEWA F, Stranix-Chibanda L, Yende-Zuma N, Dadabhai S, et al
    Bone mineral density changes in breastfeeding women living with HIV on antiretroviral therapy in Eastern and Southern Africa.
    AIDS. 2025 Feb 7. doi: 10.1097/QAD.0000000000004148.
    >> Share

  359. KNOX J, Magana C, Duncan DT, Shrader CH, et al
    Cannabis use and HIV among Black sexually minoritized men: a systematic review and narrative analysis.
    AIDS. 2025 Feb 7. doi: 10.1097/QAD.0000000000004149.
    >> Share

  360. MARSEILLE E, Walker RS, Hickey MD, Grochowski J, et al
    Cost-effectiveness of long-acting injectable cabotegravir-rilpivirine as HIV treatment per virally-suppressed persons in a San Francisco clinic: an intermediary outcome analysis.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004145.
    >> Share

  361. OGBUAGU OE, Avihingsanon A, Segal-Maurer S, Wang H, et al
    Efficacy, safety, and pharmacokinetics of lenacapavir oral bridging when subcutaneous lenacapavir cannot be administered.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004142.
    >> Share

  362. HICKS S, Jiang W, Kibugi J, Badia J, et al
    Sociobehavioral determinants of non-retention among adolescents and young adults living with HIV.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004141.
    >> Share

  363. VIGUERIE A, O'Shea J, Johnston M, Schreiber D, et al
    Impact of increased uptake of long-acting injectable antiretroviral therapy on HIV incidence and viral suppression in the United States under 2021 FDA guidelines.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004144.
    >> Share

  364. JACKSON C, Crichton S, Judd A, Bamford A, et al
    Long-term non-progression in children living with HIV: estimates from international cohort data.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004136.
    >> Share

  365. JEENA L, Ferrand RA, Simms V, Kahari C, et al
    Reduced peri-pubertal bone density accrual among Zimbabwean males living with HIV: a longitudinal study.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004134.
    >> Share

  366. DIAZ MM, Kamalyan L, Al-Rousan T, Breton J, et al
    Cerebrospinal fluid biomarkers of inflammation and immune activation associated with neurocognitive impairment among U.S. Latinos living with HIV.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004143.
    >> Share

  367. SCOFIELD D, Frisch M, Andersson M, Storgaard M, et al
    Physical, psychosocial and sexual health among people aged 50 years and above with and without HIV: a nationwide study.
    AIDS. 2025 Feb 3. doi: 10.1097/QAD.0000000000004140.
    >> Share

  368. WAGNER T, Levy I, Wieder-Finesod A, Wax M, et al
    Drug resistance testing at regimen failure in individuals diagnosed with HIV-1 between 2010 and 2018 in Israel.
    AIDS. 2025 Feb 3. doi: 10.1097/QAD.0000000000004138.
    >> Share

  369. DIEZ-VIDAL A, Gil-Garrote S, Diaz-Pollan B, Rodriguez-Sevilla G, et al
    Amebic liver abscess presenting in a nonendemic region after a 12-year latency in a patient with well controlled HIV infection.
    AIDS. 2025;39:211-213.
    >> Share

  370. BOWLER SA, Premeaux TA, Ratzan L, Friday C, et al
    Plasma anti-CD4 IgG levels are associated with poor immune recovery in people with HIV initiating antiretroviral therapy.
    AIDS. 2025;39:208-210.
    >> Share

  371. GONZALEZ-SCARANO F, Kolson DL
    Imaging brain inflammation in virally suppressed people with HIV-1.
    AIDS. 2025;39:204-205.
    >> Share

    January 2025
  372. NAIDU N, Kooij KW, Budu M, Ye M, et al
    Exploring the role of sex in hospitalizations among people with and without HIV in British Columbia, Canada.
    AIDS. 2025 Jan 31. doi: 10.1097/QAD.0000000000004135.
    >> Share

  373. BROWN MJ, Murtala NM, Amoatika D, Kaur A, et al
    Clinical and sociodemographic characteristics of alzheimer's disease and related dementias (AD/ADRD) among people living with HIV: a cross-sectional analysis.
    AIDS. 2025 Jan 31. doi: 10.1097/QAD.0000000000004137.
    >> Share

  374. SPENCER M, Pieri C, Hamzah L, Popoola J, et al
    Antiretroviral therapy in people with HIV and end-stage kidney disease.
    AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004128.
    >> Share

  375. URBINA EM, Yu W, Williams PL, Sawyer G, et al
    Central arterial stiffness in young adults with perinatal HIV exposure & infection.
    AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004129.
    >> Share

  376. HANTTU AM, Muniandy M, van der Kolk BW, Lindgren H, et al
    Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIV.
    AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004131.
    >> Share

  377. XIE X, Fu Y, Gan L, Yang X, et al
    Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study.
    AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004130.
    >> Share

  378. BLEICHRODT AM, Okano JT, Fung IC, Chowell G, et al
    The Future of HIV: Challenges in meeting the 2030 Ending the HIV Epidemic in the U.S. (EHE) reduction goal.
    AIDS. 2025 Jan 17. doi: 10.1097/QAD.0000000000004122.
    >> Share

  379. BRANTON WG, Zhang N, Cohen EA, Brew BJ, et al
    Brain RNA profiling highlights multiple disease pathways in persons with HAND: uncovering determinants of biotype diversity.
    AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004116.
    >> Share

  380. PANG X, Ma J, He Q, Tang K, et al
    Analysis of HIV transmission characteristics and intervention effects in Guangxi based on molecular networks.
    AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004123.
    >> Share

  381. PATEL VV, Andrade EA, Zimba R, Mirzayi C, et al
    Preferences for HIV PrEP care among gay, bisexual, and other men who have sex with men: a large discrete choice experiment.
    AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004124.
    >> Share

  382. LUCKETT R, Ramogola-Masire D, Zash R, Sears E, et al
    Cervical dysplasia in women with HIV in the modern treat-all era: Elevated risk remains despite long-term ART and normal CD4 count.
    AIDS. 2025 Jan 13. doi: 10.1097/QAD.0000000000004120.
    >> Share

  383. DOLLFUS C, Chenadec JL, Reliquet V, Alby-Laurent F, et al
    Outcomes and challenges in adolescents living with HIV in France: a nationwide cohort study over 35 years (1985-2020).
    AIDS. 2025 Jan 13. doi: 10.1097/QAD.0000000000004121.
    >> Share

  384. POURCHER V, Robineau O, Parienti JJ, Loubet P, et al
    Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France.
    AIDS. 2025 Jan 10. doi: 10.1097/QAD.0000000000004118.
    >> Share

  385. TAVASOLI A, Okwuegbuna OK, Tang B, Iudicello JE, et al
    Hepcidin modifies the relationship between anemia, erythrocyte indices, and neurocognitive performance in virally suppressed people with HIV.
    AIDS. 2025 Jan 7. doi: 10.1097/QAD.0000000000004110.
    >> Share

  386. HIDALGO-TENORIO C, Calle-Gomez I, Moya R, Omar M, et al
    Prevalence and incidence of HPV-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people living with HIV (PLHIV).
    AIDS. 2025 Jan 7. doi: 10.1097/QAD.0000000000004113.
    >> Share

  387. CASSIDY AR, Mayondi G, Williams PL, Moabi K, et al
    Neurodevelopmental outcomes in children exposed in utero to dolutegravir- or efavirenz-based ART.
    AIDS. 2025 Jan 6. doi: 10.1097/QAD.0000000000004111.
    >> Share

  388. VYAS KJ, Marconi VC, Agan BK, Sullivan PS, et al
    Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004105.
    >> Share

  389. BOERING P, Murray C, Portwood C, Hey M, et al
    Perinatal outcomes among pregnant women living with HIV initiating antiretroviral therapy preconception and antenatally: systematic review and meta-analysis.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004104.
    >> Share

  390. MULINGE MM, Kimani H, Inziani M, Bwana P, et al
    Trends and factors associated with HIV viral load non-suppression among treatment-experienced female sex workers in Kenya: a retrospective cohort study.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004102.
    >> Share

  391. WILLIAMS ME, Asia LK, Lindeque Z, Van Vuren EJ, et al
    The relationship between immune markers and tryptophan-kynurenine metabolites in South African people with HIV.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004103.
    >> Share


  392. The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV: Erratum.
    AIDS. 2025;39:103.
    >> Share

  393. DO NASCIMENTO AAA, Pasqualotto AC
    Fungal diseases are not in the radar of main international HIV conferences.
    AIDS. 2025;39:99-100.
    >> Share

  394. ALAGARATNAM J, Kelly N, Dustan S, Naous N, et al
    Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirine.
    AIDS. 2025;39:95-98.
    >> Share

  395. FUNDERBURG N
    Food insecurity likely contributes to frailty in people with HIV.
    AIDS. 2025;39:93-94.
    >> Share

  396. GUARALDI G, Winslow DL, Raggi P
    REPRIEVE informs on kidney disease in people with HIV.
    AIDS. 2025;39:91-92.
    >> Share

  397. BRUGUERA A, Nomah DK, Moreno-Fornes S, Martinez E, et al
    Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands.
    AIDS. 2025;39:64-74.
    >> Share

  398. BONACINA S, Lichtenstein JD, Niemczak CE, Magohe A, et al
    The relationship between HIV and reading performance for children in Tanzania.
    AIDS. 2025;39:49-56.
    >> Share

  399. VANPOUILLE C, Wells A, DeGruttola V, Lynch M, et al
    Cytokine trajectory over time in men and women with HIV on long-term antiretroviral therapy.
    AIDS. 2025;39:1-10.
    >> Share

    December 2024
  400. BILLOCK RM, France AM, Saduvala N, Panneer N, et al
    Contribution of HIV transmission bursts to future HIV infections, United States.
    AIDS. 2024 Dec 24. doi: 10.1097/QAD.0000000000004101.
    >> Share

  401. VAN ZYL GU, Jennings L, Rabie H, Orrell C, et al
    Dolutegravir regimens have transformed treatment but ongoing drug resistance research is required to maintain success.
    AIDS. 2024 Dec 23. doi: 10.1097/QAD.0000000000004099.
    >> Share

  402. RUDERMAN SA, Nance RM, Crane HM, Cachay E, et al
    Cumulative HIV viral load and lower CD4 cell count are associated with incident venous thromboembolism in people with HIV.
    AIDS. 2024 Dec 18. doi: 10.1097/QAD.0000000000004095.
    >> Share

  403. ELF JL, Lebina L, Motlhaoleng K, Chon S, et al
    A randomized trial for combination nicotine replacement therapy for smoking cessation among people with HIV in a low-resourced setting.
    AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004093.
    >> Share

  404. MIGAUD P, Pria AD, Hosmann K, Kellerher P, et al
    Hemophagocytic lymphohistiocytosis in HIV-associated HHV8-positive multicentric castleman disease.
    AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004094.
    >> Share

  405. MATTHEWS LT, Bruxvoort KJ, Jaggernath M, Kriel Y, et al
    Use of tenofovir-based PrEP among pregnant women in South Africa.
    AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004090.
    >> Share

  406. LIU B, Zhang Q
    Association between CD4 count, CD4/CD8 ratio, and fragility fractures in people living with HIV: a retrospective cohort study in China.
    AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004091.
    >> Share

  407. WANG C, Letendre SL, Hong S, Andalibi M, et al
    Differential systemic immune-inflammation index levels in people with and without HIV infection.
    AIDS. 2024 Dec 13. doi: 10.1097/QAD.0000000000004088.
    >> Share

  408. WANG T, Xu Y, Zhou S, Zhang X, et al
    Associations between salivary microbiota and KSHV infection in people with HIV: a cross-sectional study in ili prefecture, Xinjiang, China.
    AIDS. 2024 Dec 11. doi: 10.1097/QAD.0000000000004087.
    >> Share

  409. WEISSER M, Mapesi H, Vanobberghen F, Okuma J, et al
    Body weight changes in people living with HIV starting dolutegravir versus efavirenz-based regimens in a large cohort in rural Tanzania.
    AIDS. 2024 Dec 4. doi: 10.1097/QAD.0000000000004085.
    >> Share

  410. IRIARTE E, Smyth HL, Schmiege S, Tassiopoulos K, et al
    Predictors of frailty trajectories among people with HIV.
    AIDS. 2024 Dec 3. doi: 10.1097/QAD.0000000000004086.
    >> Share

  411. DREYER AJ, Le Roux C, Gf Thomas K, Sabin CA, et al
    Psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIV.
    AIDS. 2024 Dec 2. doi: 10.1097/QAD.0000000000004080.
    >> Share

  412. YEE LM, Powis KM, Jao J, Haddad LB, et al
    Substance use during pregnancy and postpartum among individuals with perinatally-acquired HIV in the United States.
    AIDS. 2024;38:2103-2107.
    >> Share

  413. BERING L, Heftdal LD, Heidari SL, Hamm SR, et al
    Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes.
    AIDS. 2024;38:2100-2103.
    >> Share

  414. PARASKEVIS D, Masenga SK
    Self-collected or staff-collected dried blood spot specimens for HIV-1 viral load testing.
    AIDS. 2024;38:2098-2099.
    >> Share

  415. SALVANA EMT, Martinez E
    Still losing sleep over HIV.
    AIDS. 2024;38:2096-2097.
    >> Share

  416. BOLZENIUS J, Agan BK
    Mitigating cognitive impairment in people with HIV by targeting potential impacts of toxoplasmic infection.
    AIDS. 2024;38:2093-2095.
    >> Share

  417. MAZZITELLI M, Trunfio M, Scaglione V, Sasset L, et al
    Multidimensional program for insomnia in a cohort of people with HIV.
    AIDS. 2024;38:2040-2049.
    >> Share

    November 2024
  418. LI W, Li G, Liu Y, Meng L, et al
    Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection.
    AIDS. 2024 Nov 29. doi: 10.1097/QAD.0000000000004079.
    >> Share

  419. HE B, Chen S, Yang X, Olatosi B, et al
    Association between substance use disorders and sustained viral suppression: a longitudinal analysis among people with HIV in South Carolina.
    AIDS. 2024 Nov 28. doi: 10.1097/QAD.0000000000004077.
    >> Share

  420. SUKUMARAN L, Sabin CA, Kunisaki KM, Doyle N, et al
    Associations between multimorbidity burden and objective and patient-reported sleep outcomes among people living with HIV.
    AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004073.
    >> Share

  421. LESKO CR, Fojo AT, Hutton HE, Falade-Nwulia OO, et al
    The effect of antidepressant treatment on viral suppression among people with HIV diagnosed with depression in an urban clinic, 2012-2023.
    AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004074.
    >> Share

  422. BAQUERO L, Stover S, Armani Tourret M, Perbelis A, et al
    Differential immunophenotype and proviral composition in young adults with perinatally acquired HIV: Are special cure strategies needed?
    AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004075.
    >> Share

  423. PAULSEN FW, Tetens MM, Gerstoft J, Kronborg G, et al
    Use of non-barrier contraceptives among women with human immunodeficiency virus; a nationwide, matched cohort study.
    AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004067.
    >> Share

  424. BROMBERG DJ, Rhoades D, Madden LM, Ivasiy R, et al
    Transformation of the HIV treatment cascade for people who inject drugs in Ukraine.
    AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004056.
    >> Share

  425. GUPTA SK, Friedman AN, Desta Z
    The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysis.
    AIDS. 2024 Nov 25. doi: 10.1097/QAD.0000000000004071.
    >> Share

  426. PAPOT E, Tovar-Sanchez T, Woods J, Thaurignac G, et al
    SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa.
    AIDS. 2024 Nov 22. doi: 10.1097/QAD.0000000000004068.
    >> Share

  427. FILIP I
    The case for integrating menopause care and HIV management.
    AIDS. 2024 Nov 22. doi: 10.1097/QAD.0000000000004069.
    >> Share

  428. AUGELLO M, Bono V, Rovito R, Santoro A, et al
    Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV.
    AIDS. 2024;38:1987-1990.
    >> Share

  429. LUISA MONTES M, Busca C, Rava M, Bernardino JI, et al
    Hepatic steatosis-insulin resistance and type 2 diabetes in people with HIV at diagnosis: effect of initial antiretroviral therapy.
    AIDS. 2024;38:1982-1987.
    >> Share

  430. SHERER R, Simon GL
    Do women with HIV, diabetes mellitus, and full antiretroviral therapy adherence have a lower rate of HIV viremia than men?
    AIDS. 2024;38:1980-1981.
    >> Share

  431. MASENGA SK, Bernardino JI
    Binge eating correlates with weight excess in people with HIV.
    AIDS. 2024;38:1978-1979.
    >> Share

  432. YAN LD, Rouzier V, Sufra R, Sauveur RST, et al
    Treatment of prehypertension among adults with HIV: a randomized clinical trial.
    AIDS. 2024 Nov 14. doi: 10.1097/QAD.0000000000004065.
    >> Share

  433. DOS SANTOS AP, Willig AL, Ruderman S, Oliveira VHF, et al
    Hazardous alcohol consumption is associated with an increased occurrence of falls among people with HIV in the PROSPER-HIV Study.
    AIDS. 2024 Nov 11. doi: 10.1097/QAD.0000000000004061.
    >> Share

  434. NOVITSKY V, Steingrimsson J, Guang A, Dunn CW, et al
    Dynamics of clustering rates in the rhode Island HIV-1 epidemic.
    AIDS. 2024 Nov 11. doi: 10.1097/QAD.0000000000004062.
    >> Share

  435. VONDER TW, Mudrikova T
    Higher non-HIV-comorbidity burden in long-term survivors.
    AIDS. 2024 Nov 6. doi: 10.1097/QAD.0000000000004054.
    >> Share

  436. FRIEDMAN MR, Wingood G, Krause KD, Krier S, et al
    Medical mistrust and vaccine-hesitant attitudes explain SARS-CoV-2 vaccination disparities in a mixed-serostatus cohort.
    AIDS. 2024 Nov 5. doi: 10.1097/QAD.0000000000004053.
    >> Share

  437. CUI Y, Moyo S, Pretorius Holme M, Hurwitz KE, et al
    Predictors of HIV seroconversion in Botswana: machine learning analysis in a representative, population-based HIV incidence cohort.
    AIDS. 2024 Nov 4. doi: 10.1097/QAD.0000000000004055.
    >> Share

  438. GOLDBERG RL, Peterson TE, Haberlen SA, Witt MD, et al
    Response to "Epicardial fat tissue and diastolic dysfunction in both men and women with HIV".
    AIDS. 2024;38:1895.
    >> Share

  439. HAN WM, Apornpong T, Tumkosit M, Avihingsanon A, et al
    Epicardial fat tissue and diastolic dysfunction in both men and women with HIV.
    AIDS. 2024;38:1893-1894.
    >> Share

  440. MUCCINI C, Gianotti N, Lolatto R, Nozza S, et al
    CD4+/CD8+ improvement after switch from a second-generation integrase inhibitor regimen to long-acting cabotegravir and rilpivirine.
    AIDS. 2024;38:1890-1892.
    >> Share

  441. MARTINEZ E, Dorfman D
    Addressing methamphetamine use in persons with HIV.
    AIDS. 2024;38:1888-1889.
    >> Share

  442. GOODKIN K, Winston A, Martinez E, Paul R, et al
    Anticholinergic and sedative medication use in persons with HIV: defining the evidence for risks on cognition.
    AIDS. 2024;38:1885-1887.
    >> Share

    October 2024
  443. SUVADA K, Kocher E, Diwan N, Nagy A, et al
    Incidence of high blood pressure among Kenyan adults living with HIV: a longitudinal cohort analysis from 2004-2023.
    AIDS. 2024 Oct 29. doi: 10.1097/QAD.0000000000004050.
    >> Share

  444. VOLLMOND CV, Tetens MM, Gerstoft J, Kronborg G, et al
    Bipolar disorder in people with HIV: A nationwide, population-based matched case-control and matched cohort study.
    AIDS. 2024 Oct 29. doi: 10.1097/QAD.0000000000004049.
    >> Share

  445. ENI-OLUTU A, Mackie NE, Glenn J, Bailey A, et al
    Emerging integrase resistance in an international perinatal virtual clinic.
    AIDS. 2024 Oct 28. doi: 10.1097/QAD.0000000000004048.
    >> Share

  446. CHAISSON LH, Durovni B, Umar N, Cohn S, et al
    Sex differences in tuberculosis infection and disease among people with HIV.
    AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004045.
    >> Share

  447. VERGORI A, Del Duca G, Lorenzini P, Brita AC, et al
    Impact of switching from EFV/F/TDF to B/F/TAF on psychiatric symptoms and neurocognition.
    AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004043.
    >> Share

  448. RUDERMAN SA, Hunt PW, Beck-Engeser G, Ambayec G, et al
    Biomarkers of microbial translocation and generalized inflammation are associated with frailty among people with HIV.
    AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004047.
    >> Share

  449. DUONG KNC, Schmutz HW, Ben-Umeh KC, Duru EE, et al
    Real-world clinical and economic outcomes from rapid start antiretroviral therapy in HIV: systematic review and meta-analysis.
    AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004046.
    >> Share

  450. SOCIO GV, Ricci E, Piconi S, Squillace N, et al
    Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort.
    AIDS. 2024 Oct 22. doi: 10.1097/QAD.0000000000004042.
    >> Share

  451. OLIVERO R, Williams PL, Sawyer G, Yee LM, et al
    Birth outcomes following bictegravir exposure during pregnancy.
    AIDS. 2024 Oct 15. doi: 10.1097/QAD.0000000000004041.
    >> Share

  452. SUMNER T, Clark RA, Prys-Jones TO, Bakker R, et al
    The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa.
    AIDS. 2024 Oct 11. doi: 10.1097/QAD.0000000000004038.
    >> Share

  453. RUBIN LH, Maki PM, Du Y, Sweeney SE, et al
    Imaging the translocator protein 18 kDa within cognitive control and declarative memory circuits in virally-suppressed people with HIV.
    AIDS. 2024 Oct 11. doi: 10.1097/QAD.0000000000004034.
    >> Share

  454. HEFFRON R, Muwonge TR, Thomas KK, Zewdie K, et al
    Bone density changes in young women in Uganda using tenofovir-based HIV pre-exposure prophylaxis and depot medroxyprogesterone acetate contraception.
    AIDS. 2024 Oct 9. doi: 10.1097/QAD.0000000000004029.
    >> Share

  455. HEY M, Thompson L, Portwood C, Sexton H, et al
    Adverse perinatal outcomes associated with different classes of antiretroviral drugs in pregnant women living with HIV: a systematic review and meta-analysis.
    AIDS. 2024 Oct 8. doi: 10.1097/QAD.0000000000004032.
    >> Share

  456. FILIP I
    Person-centered pre-exposure prophylaxis: the next wave of innovation in HIV prevention.
    AIDS. 2024 Oct 7. doi: 10.1097/QAD.0000000000004030.
    >> Share

  457. SIREGAR T, Weriditi RK, Reba YA, Muttaqin MZ, et al
    Impact of COVID-19 vaccination on HIV parameters in people with HIV on antiretroviral therapy.
    AIDS. 2024;38:1807-1808.
    >> Share

  458. CLEMENTE T, Pontillo D, Malagnino V, Calza L, et al
    Cancer in people with multidrug-resistant HIV.
    AIDS. 2024;38:1801-1806.
    >> Share

  459. LEAL M, Kerr L, Mota RMS, Motta-Castro ARC, et al
    Increasing HIV prevalence rate among men who have sex with men: results of a comparison of two national surveys.
    AIDS. 2024;38:1799-1801.
    >> Share

  460. GOUVEA-E-SILVA LF
    Challenges in clinical monitoring of people with HIV: evolution from prediabetes mellitus to diabetes mellitus.
    AIDS. 2024;38:1796-1798.
    >> Share

  461. NICOL MR, Dawood H, Hoy JF
    Deconvoluting the contribution of antiretroviral choice in weight gain.
    AIDS. 2024;38:1794-1795.
    >> Share

    September 2024
  462. WIJSTMA E, Jongen VW, Boyd A, de Vries HJC, et al
    Outcomes of a policy to prioritize populations with expected healthcare barriers for subsidized PrEP care in Amsterdam, the Netherlands: a cross-sectional study.
    AIDS. 2024 Sep 30. doi: 10.1097/QAD.0000000000004027.
    >> Share

  463. PASTORI D, Del Sole F, Brogi T, Del Ben M, et al
    Epicardial fat and liver stiffness by ARFI elastography in people living with Human Immunodeficiency Virus type 1 (HIV-1) infection without liver disease.
    AIDS. 2024 Sep 30. doi: 10.1097/QAD.0000000000004028.
    >> Share

  464. BROCHON J, Ducruet T, Taillefer S, Lamarre V, et al
    Increased risk of hospitalization among children who were HIV-exposed and uninfected compared to population controls.
    AIDS. 2024 Sep 27. doi: 10.1097/QAD.0000000000004025.
    >> Share

  465. REID MJA, Bunnell R, Davis M, Carter H, et al
    Sustaining two decades of PEPFAR's response to global HIV/AIDS: mitigating the impact of climate threats.
    AIDS. 2024 Sep 23. doi: 10.1097/QAD.0000000000004023.
    >> Share

  466. LAM JO, Hou CE, Lee C, Samiezade-Yazd Z, et al
    Hypertension control and risk of age-associated dementia in people with hiv infection.
    AIDS. 2024 Sep 18. doi: 10.1097/QAD.0000000000004017.
    >> Share

  467. YADAV A, Gionet G, Karaj A, Kossenkov AV, et al
    Association of smoking with neurocognition, inflammatory and myeloid cell activation profiles in people with HIV on ART.
    AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004015.
    >> Share

  468. UELAND T, Nkele I, Hoel H, Lockman S, et al
    Markers of extracellular matrix degradation and inflammasome activation are associated with carotid plaques in virally suppressed people with HIV in Botswana.
    AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004014.
    >> Share

  469. FILIP I
    Twice-yearly lenacapavir may change the standard of HIV prevention for women.
    AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004013.
    >> Share

  470. OVERTON ET, Kantor A, Fitch KV, Mosepele M, et al
    Proteinuria and albuminuria among a global primary CVD prevention cohort of PWH: prevalence and associated factors.
    AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004016.
    >> Share

  471. SAHU M, Schaafsma T, Szpiro AA, Van Rooyen H, et al
    Performance of patient-collected dried blood spot specimens for HIV-1 viral load testing: evidence from the DO ART Study in South Africa.
    AIDS. 2024 Sep 13. doi: 10.1097/QAD.0000000000004011.
    >> Share

  472. KUNIHOLM MH, Murenzi G, Shumbusho F, Brazier E, et al
    Association of cardiovascular disease risk with liver steatosis and fibrosis in people living with hiv in low- and middle-income countries.
    AIDS. 2024 Sep 12. doi: 10.1097/QAD.0000000000004012.
    >> Share

  473. CUMMINGS TH, Magagnoli J, Sikirzhytskaya S, Tyagin I, et al
    Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among People Living with HIV.
    AIDS. 2024 Sep 10. doi: 10.1097/QAD.0000000000004009.
    >> Share

  474. ZANIEWSKI E, Skrivankova VW, Brazier E, Avihingsanon A, et al
    Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics.
    AIDS. 2024 Sep 5. doi: 10.1097/QAD.0000000000004007.
    >> Share

  475. RUDERMAN SA, Willig AL, Cleveland JD, Burkholder G, et al
    Low food security is associated with frailty status and frailty components among people with HIV.
    AIDS. 2024 Sep 4. doi: 10.1097/QAD.0000000000004006.
    >> Share

  476. EUSTAQUIO PC, Burnett J, Prejean J, Chapin-Bardales J, et al
    Changes in HIV Pre-exposure Prophylaxis Awareness and Use Among Males Who Inject Drugs Who Have Sex with Men by Sexual Identity, 19 US Urban Areas, 2018 & 2022.
    AIDS. 2024 Sep 3. doi: 10.1097/QAD.0000000000004005.
    >> Share

  477. ZHAO R, Sanstead E, Alarid-Escudero F, Huchko M, et al
    Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study.
    AIDS. 2024 Sep 2. doi: 10.1097/QAD.0000000000004002.
    >> Share

  478. FILIP I
    Perinatal exposure to HIV leaves a lasting neurocognitive mark - even when vertical transmission is prevented.
    AIDS. 2024 Sep 2. doi: 10.1097/QAD.0000000000004004.
    >> Share

  479. BURGER D, Wttewaal E, Oosterhof P, Stalenhoef J, et al
    Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance.
    AIDS. 2024;38:1728-1729.
    >> Share

  480. PRYKE LA, Liu Z, Khaitan AK, Sims EK, et al
    Immune checkpoints and pancreatic beta cell dysfunction in HIV.
    AIDS. 2024;38:1725-1727.
    >> Share

  481. TREVILLYAN JM, Dart A, Paul E, Dewar EM, et al
    Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk.
    AIDS. 2024;38:1722-1724.
    >> Share

  482. MUCHAILI L, Masenga SK
    Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV.
    AIDS. 2024;38:1720-1721.
    >> Share

    August 2024
  483. TARAMASSO L, Dentone C, Cama I, Fenoglio D, et al
    Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV.
    AIDS. 2024 Aug 30. doi: 10.1097/QAD.0000000000004001.
    >> Share

  484. NEARY J, Chebet D, Benki-Nugent S, Moraa H, et al
    Association between HIV and cytomegalovirus and neurocognitive outcomes among children with HIV.
    AIDS. 2024 Aug 29. doi: 10.1097/QAD.0000000000004000.
    >> Share

  485. CRAWFORD TN, Neilands TB, Drumright LN, Fredericksen RJ, et al
    Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support.
    AIDS. 2024 Aug 29. doi: 10.1097/QAD.0000000000003999.
    >> Share

  486. HYBEL TE, Sorensen EF, Enemark MH, Hemmingsen JK, et al
    Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes.
    AIDS. 2024 Aug 22. doi: 10.1097/QAD.0000000000003996.
    >> Share

  487. CAPELL-MORELL M, Bradbury M, Dinares MC, Hernandez J, et al
    Anal high-grade intraepithelial neoplasia and cancer in women living with HIV and HIV-negative women with other risk factors.
    AIDS. 2024 Aug 14. doi: 10.1097/QAD.0000000000003995.
    >> Share

  488. DIAZ MM, Mccutchan JA, Crescini M, Tang B, et al
    Longitudinal Study of Cognitive Function in People with HIV and Toxoplasmic Encephalitis or Latent toxoplasma Infection.
    AIDS. 2024 Aug 9. doi: 10.1097/QAD.0000000000003992.
    >> Share

  489. SILVA MS, Torres TS, Coutinho C, Jalil EM, et al
    Mpox, sexually transmitted infections and combination prevention: insights from a major cohort in Rio de Janeiro, Brazil.
    AIDS. 2024 Aug 9. doi: 10.1097/QAD.0000000000003991.
    >> Share

  490. FILIP I
    Uneven progress in reducing mortality in people with HIV underscores the need for interventions focused on vulnerable populations.
    AIDS. 2024 Aug 9. doi: 10.1097/QAD.0000000000003993.
    >> Share

  491. PATEL PB, Prince DK, Bolenzius J, Chen P, et al
    Medical comorbidities and lower myelin content are associated with poor cognition in young adults with perinatally acquired HIV.
    AIDS. 2024 Aug 7. doi: 10.1097/QAD.0000000000003989.
    >> Share

  492. ALDREDGE A, Mehta CC, Lahiri CD, Schneider MF, et al
    Consequences of low-level viremia among women with HIV in the United States from 2003 - 2020.
    AIDS. 2024 Aug 7. doi: 10.1097/QAD.0000000000003990.
    >> Share

  493. ZEWDIE K, Muwonge T, Ssebuliba T, Bambia F, et al
    A point-of-care tenofovir urine test improves accuracy of self-reported PrEP adherence and increases condomless sex reporting among young women.
    AIDS. 2024 Aug 2. doi: 10.1097/QAD.0000000000003988.
    >> Share


  494. Initial antiretroviral therapy regimen and risk of heart failure: Erratum.
    AIDS. 2024;38:1608.
    >> Share


  495. Dolutegravir-induced neural tube defects in mice are folate responsive: Erratum.
    AIDS. 2024;38:1607.
    >> Share


  496. The association between anticholinergic/sedative burden and physical frailty in people aging with HIV: Erratum.
    AIDS. 2024;38:1606.
    >> Share

  497. ELAHI S
    Galectin-9, a lingering shadow in HIV's fight: the unseen battle of adolescents with perinatally-acquired HIV.
    AIDS. 2024;38:1589-1591.
    >> Share

  498. KOHLER P, Larsen A, Abuna F, Owiti G, et al
    Patient actor training improves preexposure prophylaxis delivery for adolescent girls and young women in Kenya: a cluster randomized trial.
    AIDS. 2024;38:1505-1512.
    >> Share

  499. ZALLA LC, Hutton HE, Fojo AT, Falade-Nwulia OO, et al
    The anxiety care continuum and its association with viral suppression among persons with HIV.
    AIDS. 2024 Aug 1. doi: 10.1097/QAD.0000000000003986.
    >> Share

  500. HURCHUND R, Sibiya SE, Owaga BO, Owira PMO, et al
    Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats.
    AIDS. 2024 Aug 1. doi: 10.1097/QAD.0000000000003987.
    >> Share

  501. BOZZI G, Centazzo M, Scaglioni S, Butta GM, et al
    Primary HIV infection during chronic treatment with imatinib: impact on infection dynamics.
    AIDS. 2024;38:1601-1604.
    >> Share

  502. CHAMBERS C, Cooper CL, Kroch AE, Buchan SA, et al
    Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves.
    AIDS. 2024;38:1597-1600.
    >> Share

  503. LINFIELD RY, Slusky DJG, Moskatel LS
    The impact of Mpox virus incidence and Mpox virus first-dose vaccination on recent HIV testing.
    AIDS. 2024;38:1595-1597.
    >> Share

    July 2024
  504. MANJI KP, Muhihi A, Duggan CP, Alwy Al-Beity FM, et al
    Fetal, neonatal, and infant death among offspring of pregnant women living with HIV in Tanzania.
    AIDS. 2024 Jul 31. doi: 10.1097/QAD.0000000000003985.
    >> Share

  505. KAMPOURI E, Damas J, Kusejko K, Ledergerber B, et al
    Prevalence of HIV-related stigma among people with HIV in Switzerland: addressing the elephant in the room.
    AIDS. 2024 Jul 25. doi: 10.1097/QAD.0000000000003983.
    >> Share

  506. MANN SC, Tong W, Abraham AG, Palella F, et al
    The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study.
    AIDS. 2024 Jul 19. doi: 10.1097/QAD.0000000000003978.
    >> Share

  507. STONER MCD, Kelly NK, Gomez-Olive FX, Mall S, et al
    Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa: A HPTN 068 case cohort study.
    AIDS. 2024 Jul 18. doi: 10.1097/QAD.0000000000003981.
    >> Share

  508. DUFFY CR, Herlihy JM, Zulu E, Mwananyanda L, et al
    Preterm birth among women living with HIV: impact of preconception cART initiation.
    AIDS. 2024 Jul 17. doi: 10.1097/QAD.0000000000003979.
    >> Share

  509. TEJEDOR MT, Rial-Crestelo D, Diab L, de Lagarde M, et al
    Fibrocavitary disease caused by Mycobacterium chimaera in a patient with HIV.
    AIDS. 2024;38:1446-1448.
    >> Share

  510. CAMPBELL L, Barbini B, Cromarty B, Hamzah L, et al
    Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxil.
    AIDS. 2024;38:1442-1445.
    >> Share

  511. JOHNSON AT, Ntloedibe T, Mendez Reyes JE, Matshaba MS, et al
    Impact of efavirenz on hormone-positive breast cancer survival in women living with HIV.
    AIDS. 2024;38:1439-1442.
    >> Share

  512. MATHUR P, Ramadhani HO, Kaplan R, Stafford KA, et al
    Interferon-free hepatitis C treatment increases a surrogate of atherosclerotic cardiovascular disease risk in Black veterans living with HIV.
    AIDS. 2024;38:1437-1439.
    >> Share

  513. MATSENA-ZINGONI Z, Blower S
    Successful control of HIV in sub-Saharan Africa is causing a new problem.
    AIDS. 2024;38:1435-1436.
    >> Share

  514. MAUSS S, Stapleton JT, Thomas DL
    Steatotic liver disease progression in persons with HIV: weighting for answers.
    AIDS. 2024;38:1432-1434.
    >> Share

  515. HILL AM, Elbirt D
    Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial.
    AIDS. 2024;38:1430-1431.
    >> Share

  516. YAN Y, Yuan R, Deng L, Hu H, et al
    The construction of a novel supplementary diagnostic model for patients with indeterminate HIV infection: a proteomics study.
    AIDS. 2024 Jul 15. doi: 10.1097/QAD.0000000000003977.
    >> Share

  517. BAMFORD L, Rajagopal A, Grelotti D, Justice-Royster V, et al
    Impact of methamphetamine use on HIV and other health outcomes at an urban HIV medicine clinic.
    AIDS. 2024 Jul 3. doi: 10.1097/QAD.0000000000003975.
    >> Share

  518. WILLIAMS LD, van Heerden A, Friedman SR, Chibi B, et al
    Comparison of a novel expanded social network recruitment intervention with risk network recruitment to HIV testing: locating undiagnosed cases in South Africa.
    AIDS. 2024 Jul 3. doi: 10.1097/QAD.0000000000003976.
    >> Share

  519. SILHOL R, Maheu-Giroux M, Soni N, Fotso AS, et al
    The impact of past HIV interventions and diagnosis gaps on new HIV acquisitions, transmissions, and HIV-related deaths in Cote d'Ivoire, Mali, and Senegal.
    AIDS. 2024 Jul 2. doi: 10.1097/QAD.0000000000003974.
    >> Share

  520. KING EM, Tkachuk S, Tseng A
    Aging on Antiretrovirals: Reviewing the need for pharmacologic data in elderly people living with HIV.
    AIDS. 2024 Jul 2. doi: 10.1097/QAD.0000000000003973.
    >> Share


  521. Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals: Erratum.
    AIDS. 2024;38:1280.
    >> Share


  522. Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV: Erratum.
    AIDS. 2024;38:1279.
    >> Share

  523. DE S CARVALHO R, Rangel IC, Ferry FRA
    Towards a refined understanding of cerebrospinal fluid CXCL13 in neurosyphilis diagnosis among people with HIV.
    AIDS. 2024;38:1275-1278.
    >> Share

  524. TRUNFIO M, Bonora S, di Perri G, Calcagno A, et al
    Further considerations on the use of cerebrospinal fluid C-X-C motif chemokine ligand 13 in the diagnosis of neurosyphilis among people with HIV.
    AIDS. 2024;38:1273-1275.
    >> Share

  525. KARABAY O
    Concerns and clarifications regarding the article 'Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first line ART regimen in Zimbabwe'.
    AIDS. 2024;38:1273.
    >> Share

  526. LEROY P, Diamantis S, Sellier PO, Hamet G, et al
    Prescriptions of generic antiretroviral drugs in three healthcare centers in the Paris area, France.
    AIDS. 2024;38:1269-1272.
    >> Share

  527. RUBENSTEIN E, Diemer M, Goldwirt L, Lascoux-Combe C, et al
    Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine.
    AIDS. 2024;38:1267-1269.
    >> Share

  528. ABDEL-HAMEED EA, Masenga SK
    HIV-related gut damage persists long-term in perinatally acquired HIV and is associated with insulin resistance.
    AIDS. 2024;38:1265-1266.
    >> Share

  529. WINSLOW DL
    Is early initiation of antiretroviral therapy important?
    AIDS. 2024;38:1263-1264.
    >> Share

  530. MOOLLA H, Davies MA, Davies C, Euvrard J, et al
    The effect of care interruptions on mortality in adults resuming antiretroviral therapy.
    AIDS. 2024;38:1198-1205.
    >> Share

    June 2024
  531. GRAM EJPN, Moseholm E, Norlov AB, Wilken-Jensen C, et al
    Cervical cancer screening integrated in routine clinical care of women living with HIV.
    AIDS. 2024 Jun 28. doi: 10.1097/QAD.0000000000003972.
    >> Share

  532. WU C, Xu X, Peng C, Lou Z, et al
    Cost-effectiveness of different intervention strategies of human immunodeficiency virus in Zhejiang, China: a Model Study From 2023 to 2052.
    AIDS. 2024 Jun 26. doi: 10.1097/QAD.0000000000003968.
    >> Share

  533. MASTERS MC, Tassiopoulos K, Bao Y, Wu K, et al
    Risk factors for progression from prediabetes to diabetes among older persons with HIV.
    AIDS. 2024 Jun 26. doi: 10.1097/QAD.0000000000003970.
    >> Share

  534. MARTINSON T, Montoya R, Moreira C, Kuncze K, et al
    Point-of-care urine tenofovir test predicts future HIV pre-exposure prophylaxis discontinuation among young users.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003962.
    >> Share

  535. KING JM, Dobbins T, Keen P, Cornelisse VJ, et al
    Trends in HIV testing and HIV stage at diagnosis among people newly diagnosed with HIV.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003961.
    >> Share

  536. YOTEBIENG M, Zotova N, Bernard C, Goodrich S, et al
    Accuracy of PHQ-9 against psychiatric diagnosis for depression among people living with HIV: A multicounty cross-sectional study.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003963.
    >> Share

  537. MICHAEL HU, Brouillette MJ, Tamblyn R, Fellows LK, et al
    Cognitive impact of anticholinergic and sedative burden in people living with HIV.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003966.
    >> Share

  538. ROSE PC, Davies C, Cotton MF, Otwombe K, et al
    Longitudinal controlled attenuation parameter and liver stiffness in children with and without perinatal HIV infection in South Africa.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003964.
    >> Share

  539. SCHNITTMAN SR, Talathi R, Wilks MQ, Hedgire S, et al
    Association of T-cell subtypes with macrophage-specific arterial infiltration in PWH.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003967.
    >> Share

  540. RUSSO SC, Ockene MW, Arpante AK, Johnson JE, et al
    Efficacy and safety of tesamorelin in people with hiv on integrase inhibitors.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003965.
    >> Share

  541. BLAIR J, Kempf MC, Dionne JA, Causey-Pruitt Z, et al
    Awareness, treatment, and control of hypertension among women at risk or living with HIV in the US South: a prospective study.
    AIDS. 2024 Jun 20. doi: 10.1097/QAD.0000000000003960.
    >> Share

  542. FILIP I
    Decoding the effects of statins on cardiovascular risk: are we closer to better risk-prediction tools for people with HIV?
    AIDS. 2024 Jun 19. doi: 10.1097/QAD.0000000000003958.
    >> Share

  543. SODEKE O, Milligan K, Ezeuko I, Oladipo A, et al
    Longitudinal viral load outcomes of adults with HIV after detectable viremia on tenofovir, lamivudine, and dolutegravir.
    AIDS. 2024 Jun 13. doi: 10.1097/QAD.0000000000003956.
    >> Share

  544. FUNG K, Hernandez-Diaz S, Zash R, Chadwick EG, et al
    First-trimester exposure to newer antiretroviral agents and congenital anomalies in a U.S. cohort.
    AIDS. 2024 Jun 12. doi: 10.1097/QAD.0000000000003955.
    >> Share

  545. HWANG YJ, Lesko CR, Brown TT, Alexander GC, et al
    Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV: a longitudinal cohort study.
    AIDS. 2024 Jun 12. doi: 10.1097/QAD.0000000000003954.
    >> Share

  546. MAZZITELLI M, Cozzolino C, Gasparini G, Chiaro E, et al
    Weight excess and obesity are associated with binge eating behaviours in people with HIV.
    AIDS. 2024 Jun 10. doi: 10.1097/QAD.0000000000003953.
    >> Share

  547. DRECHSLER H, Ayers C, Oboho I, Enwerem N, et al
    Choice of antiretroviral therapy has low impact on weight gain.
    AIDS. 2024 Jun 3. doi: 10.1097/QAD.0000000000003950.
    >> Share

  548. KUROSAWA S, Yoshimura Y, Takada Y, Yokota T, et al
    A predictive model for HIV-related lymphoma: a case series and literature review in Japan.
    AIDS. 2024 Jun 3. doi: 10.1097/QAD.0000000000003949.
    >> Share

  549. ALIBUDBUD R
    Navigating the intersection: minority stress, mental health, and HIV care in the Philippines.
    AIDS. 2024;38:1097-1099.
    >> Share

  550. LEMOINE S, Bobo M, Hocqueloux L, Legac E, et al
    Dolutegravir-induced severe sideroblastic anemia.
    AIDS. 2024;38:1095-1097.
    >> Share

  551. HARRINGTON J, McCrary AW, Nguyen M, Nyandiko W, et al
    Proteomics discovery in children and young adults with HIV identifies fibrosis, inflammatory, and immune biomarkers associated with myocardial impairment.
    AIDS. 2024;38:1090-1093.
    >> Share

  552. RAIFORD JL, Tie Y, Yuan XA, Byrd KK, et al
    Progress towards achieving national goals for improved quality of life among cis-gender Black women with HIV.
    AIDS. 2024;38:1087-1090.
    >> Share

  553. MEYER L, Schim van der Loeff MF
    Sexually transmitted infections in the preexposure prophylaxis era.
    AIDS. 2024;38:1085-1086.
    >> Share

  554. VANCE DE, Brew BJ
    Plasma neurofilament light chain protein predicts greater brain-age gap, cognition, and cardiovascular risk in people with HIV.
    AIDS. 2024;38:1081-1083.
    >> Share

  555. GOYAL R, Hotchkiss J, Gilman B, Klein PW, et al
    The health equity implications of the Health Resources and Services Administration's Ryan White HIV/AIDS Program.
    AIDS. 2024;38:1025-1032.
    >> Share

    May 2024
  556. WASILWA A, Amadi E, Ramadhani HO, Lascko T, et al
    Impact of enhanced adherence counselling on viral re-suppression among adolescents and young persons with persistent viremia.
    AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003945.
    >> Share

  557. ZHANG M, Dai G, Smith DL, Zacco E, et al
    Interferon signaling pathways are upregulated in people with hiv with abnormal pulmonary diffusing capacity (DLCO).
    AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003946.
    >> Share

  558. MCCABE L, Burns JE, Latifoltojar A, Post FA, et al
    MAVMET trial: maraviroc and/or metformin for metabolic dysfunction-associated fatty liver disease(MAFLD) in adults with suppressed HIV.
    AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003947.
    >> Share

  559. CHITLE P, Sheira LA, Katabaro E, Winters S, et al
    The Impact of Financial Incentives on Mental Health among Adults in HIV Care in Lake Zone, Tanzania: A Two-Arm Randomized Controlled Trial.
    AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003948.
    >> Share

  560. ZHAO J, Zhou X, Qiu Y, Jia R, et al
    Characterization of the gut butyrate-producing bacteria and lipid metabolism in African green monkey as a natural host of SIV infection.
    AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003944.
    >> Share

  561. NJUGUNA C, Long L, Mistri P, Chetty-Makkan C, et al
    A randomised trial of "Fresh Start" text messaging to improve return to care in people living with HIV who missed appointments in South Africa.
    AIDS. 2024 May 29. doi: 10.1097/QAD.0000000000003939.
    >> Share

  562. WAGNER TA, Tierney C, Huang S, Nichols S, et al
    Prevalence of detectable HIV-DNA and -RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy.
    AIDS. 2024 May 29. doi: 10.1097/QAD.0000000000003937.
    >> Share

  563. SMITH AC, Goulet JL, Vlahov D, Justice AC, et al
    Self-injurious unnatural death among Veterans with HIV: a nested case-control study.
    AIDS. 2024 May 29. doi: 10.1097/QAD.0000000000003940.
    >> Share

  564. JONGKEES MJ, Tan NH, Geers D, de Vries RD, et al
    Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.
    AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003933.
    >> Share

  565. KAMITANI E, Mizuno Y, Khalil GM, Viguerie A, et al
    Improving HIV Pre-exposure Prophylaxis Uptake with Artificial Intelligence and Automation: A Systematic Review.
    AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003935.
    >> Share

  566. GOLDBERG RL, Peterson TE, Haberlen SA, Witt MD, et al
    Associations between epicardial, visceral and subcutaneous adipose tissue with diastolic function in men with and without HIV.
    AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003936.
    >> Share

  567. GUIGUES A, Gimenez S, Mettling C, Maurel D, et al
    The EBI2 receptor is coexpressed with CCR5 in CD4+ T cells and boosts HIV-1 R5 replication.
    AIDS. 2024 May 21. doi: 10.1097/QAD.0000000000003931.
    >> Share

  568. CHANDASANA H, Hayes S, Buchanan AM, Brothers C, et al
    Bridging dolutegravir clinical viral response across doses and formulations using model-based exposure-response analysis in pediatrics.
    AIDS. 2024 May 20. doi: 10.1097/QAD.0000000000003929.
    >> Share

  569. WEISER SD, Sheira LA, Weke E, Zakaras JM, et al
    An agricultural livelihood intervention is associated with reduced HIV stigma among people living with HIV.
    AIDS. 2024 May 16. doi: 10.1097/QAD.0000000000003928.
    >> Share

  570. MATTHEWS LT, Jaggernath M, Kriel Y, Smith PM, et al
    Oral PrEP uptake, adherence, and persistence during periconception periods among women in South Africa: an intervention study.
    AIDS. 2024 May 15. doi: 10.1097/QAD.0000000000003925.
    >> Share

  571. KELLY NK, Ranapurwala SI, Pence BW, Hightow-Weidman LB, et al
    The relationship between anti-LGBTQ+ legislation and HIV prevention among sexual and gender minoritized youth.
    AIDS. 2024 May 14. doi: 10.1097/QAD.0000000000003926.
    >> Share

  572. XIA Q, Edelstein ZR, Katz B, Bertolino D, et al
    Impact of HIV pre-exposure prophylaxis prescriptions on HIV diagnoses in New York city.
    AIDS. 2024 May 14. doi: 10.1097/QAD.0000000000003927.
    >> Share

  573. TRICKEY A, Zhang L, Rentsch CT, Pantazis N, et al
    Care interruptions and mortality among adults in Europe and North America: a collaborative analysis of cohort studies.
    AIDS. 2024 May 8. doi: 10.1097/QAD.0000000000003924.
    >> Share

  574. BAI F, Bono V, Borghi L, Bonazza F, et al
    Association between tight junction proteins and cognitive performance in untreated Persons living with HIV (PLWH).
    AIDS. 2024 May 3. doi: 10.1097/QAD.0000000000003923.
    >> Share


  575. Sex differences in incident atherosclerotic cardiovascular disease events among women and men with HIV: Erratum.
    AIDS. 2024;38:935.
    >> Share

  576. BLOT-COSSARD A, Merad Y, Bachelard A, Lebreton C, et al
    Epidemiology and characteristics of Paget's disease of bone in a French nationwide HIV cohort.
    AIDS. 2024;38:929-931.
    >> Share

  577. BARR EA
    Vespers: A nursing origin story set in the dawn of the HIV pandemic.
    AIDS. 2024;38:925-927.
    >> Share

  578. FEENEY ER, Boix V, Hsue PY
    Chronotropic incompetence in HIV infection.
    AIDS. 2024;38:921-923.
    >> Share

  579. ABDEL-HAMEED EA, Overton ET
    What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?
    AIDS. 2024;38:917-919.
    >> Share

  580. GOTTERT A, Malone S, Pulerwitz J
    The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa.
    AIDS. 2024;38:913-915.
    >> Share

  581. OURSLER KK, Briggs BC, Lozano AJ, Harris NM, et al
    Association of chronotropic incompetence with reduced cardiorespiratory fitness in older adults with HIV.
    AIDS. 2024;38:825-833.
    >> Share

  582. LI N, Zheng HY, He WQ, He XY, et al
    Treatment outcomes amongst older people with HIV infection receiving antiretroviral therapy.
    AIDS. 2024;38:803-812.
    >> Share

  583. JIANG J, Wang L, Li Q, Wang Y, et al
    HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood-retinal barrier.
    AIDS. 2024;38:779-789.
    >> Share

  584. SALTO JN, Volkow P, Herrera-Goepfert R, Lopez-Garcia AI, et al
    Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS.
    AIDS. 2024;38:933-934.
    >> Share

    April 2024
  585. BRICKMAN CE, Agnello M, Imam N, Camejo P, et al
    Distinct anal microbiome is correlated with anal cancer precursors in men who have sex with men living with HIV.
    AIDS. 2024 Apr 30. doi: 10.1097/QAD.0000000000003920.
    >> Share

  586. DERSEH NM, Agimas MC, Tesfie TK
    Risk score prediction for bacteriologically confirmed tuberculosis among HIV-infected adults on antiretroviral therapy in Ethiopia: prognostic model development.
    AIDS. 2024 Apr 25. doi: 10.1097/QAD.0000000000003917.
    >> Share

  587. FILIP I
    Liver health matters: targeting modifiable factors to reduce the risk of advanced liver disease in people with HIV.
    AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003915.
    >> Share

  588. SAURA-LAZARO A, Augusto O, Fernandez-Luis S, Lopez-Varela E, et al
    HIV care retention in three multi-month ART dispensing: a retrospective cohort study in Mozambique.
    AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003913.
    >> Share

  589. ZHAO J, Dong Y, Clark E, Garcia JM, et al
    Risk and predictors of penile cancer in US Veterans with HIV.
    AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003914.
    >> Share

  590. KADIYALA GN, Telwatte S, Wedrychowski A, Janssens J, et al
    Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small molecules.
    AIDS. 2024 Apr 16. doi: 10.1097/QAD.0000000000003908.
    >> Share

  591. MOAR P, Linn K, Premeaux TA, Bowler S, et al
    Plasma Galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV.
    AIDS. 2024 Apr 12. doi: 10.1097/QAD.0000000000003907.
    >> Share

  592. FLORES JM, Moline T, Regan SD, Chen YT, et al
    Neighborhood violent crime exposure is associated with PrEP non-use among black sexually minoritized men and transgender women: A GPS Study.
    AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003906.
    >> Share

  593. JANG Y, Kim T, Choi Y, Ahn KH, et al
    Association between obesity and cancer risk in HIV-infected Asians.
    AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003904.
    >> Share

  594. OOSTERHOF P, Van Luin M, Brinkman K, Burger DM, et al
    Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen.
    AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003905.
    >> Share

  595. GUARALDI G, Milic J, Renzetti S, Motta F, et al
    The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV.
    AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003903.
    >> Share

  596. SABERIAN C, Lurain K, Hill LK, Marshall V, et al
    Kaposi sarcoma herpesvirus viral load in bronchoalveolar lavage as a diagnostic marker for pulmonary Kaposi sarcoma.
    AIDS. 2024 Apr 2. doi: 10.1097/QAD.0000000000003897.
    >> Share


  597. Prevalence and incidence of stroke among people with HIV: Erratum.
    AIDS. 2024;38:777.
    >> Share

  598. DE COCK KM, El-Sadr WM
    Authors' response to comment on 'Invisible, but not absent'.
    AIDS. 2024;38:774-775.
    >> Share

  599. AMON JJ
    To end AIDS, human rights must remain at the center of the HIV response.
    AIDS. 2024;38:773-774.
    >> Share

  600. FRESSE A, Massy N, Fournier D, Pinel S, et al
    Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemic.
    AIDS. 2024;38:768-771.
    >> Share

  601. FRASER D, Holt M, Ong JJ, Bourne C, et al
    A proposal for a simplified measure of HIV preexposure prophylaxis prevention-effective adherence in self-report questionnaires.
    AIDS. 2024;38:765-767.
    >> Share

  602. GONZALEZ-SCARANO F, Napravnik S, Vance DE
    Frailty and HIV-associated neurocognitive disorder are only modestly associated.
    AIDS. 2024;38:757-759.
    >> Share

  603. GOODREAU SM, Wohlfeiler DA, Bertrand T
    Bringing back condoms.
    AIDS. 2024;38:761-763.
    >> Share

  604. WILKINSON L, Grimsrud A
    Enabling effective differentiated service delivery transitions for people on antiretroviral treatment.
    AIDS. 2024;38:615-622.
    >> Share

    March 2024
  605. DIRAJLAL-FARGO S, Yu W, Jacobson DL, Mirza A, et al
    Gut permeability is associated with lower insulin sensitivity in youth living with perinatally-acquired HIV.
    AIDS. 2024 Mar 28. doi: 10.1097/QAD.0000000000003896.
    >> Share

  606. SULLIVAN EV, Zahr NM, Zhao Q, Pohl KM, et al
    Contributions of cerebral white matter hyperintensities, age, and pedal perception to postural sway in people living with HIV.
    AIDS. 2024 Mar 27. doi: 10.1097/QAD.0000000000003894.
    >> Share

  607. SCHNURE MC, Kasaie P, Dowdy DW, Genberg BL, et al
    Forecasting the effect of HIV-targeted interventions on the age distribution of people living with HIV: a case study from Kenya.
    AIDS. 2024 Mar 27. doi: 10.1097/QAD.0000000000003895.
    >> Share

  608. GIANELLA S, Anderson C, Chaillon A, Wells A, et al
    Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy.
    AIDS. 2024 Mar 25. doi: 10.1097/QAD.0000000000003882.
    >> Share

  609. WIJSTMA ES, Jongen VW, Boyd A, van den Elshout M, et al
    Concordance between daily diary reported PrEP intake and intraerythrocytic tenofovir diphosphate (TFV-DP) in the Amsterdam PrEP demonstration project.
    AIDS. 2024 Mar 21. doi: 10.1097/QAD.0000000000003889.
    >> Share

  610. KEMP CG, Pence BW, Velloza J, Concepcion T, et al
    Cumulative exposure to depressive symptoms and all-cause mortality among adults living with HIV in Kenya, Nigeria, Tanzania, and Uganda.
    AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003891.
    >> Share

  611. MIGISHA R, Chen G, Muyindike WR, Aung TN, et al
    Regional variation in weight change after the transition to dolutegravir: a prospective cohort study in Uganda and South Africa.
    AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003888.
    >> Share

  612. CHOLLI PA, Buchacz KM, Harris NS, Crim SM, et al
    Self-rated Health and HIV Outcomes Among Adults with Diagnosed HIV - Medical Monitoring Project, United States, 2020-21.
    AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003890.
    >> Share

  613. HAW NJL, Lesko CR, Ng DK, Lam J, et al
    Incidence of non-AIDS defining comorbidities among young adults with perinatally-acquired HIV in North America, 2000-2019.
    AIDS. 2024 Mar 19. doi: 10.1097/QAD.0000000000003892.
    >> Share

  614. HU FH, Tang XL, Ge MW, Jia YJ, et al
    Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis.
    AIDS. 2024 Mar 18. doi: 10.1097/QAD.0000000000003886.
    >> Share

  615. HIMELHOCH SS, Shuter J
    Authors' response to 'Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment'.
    AIDS. 2024;38:614.
    >> Share

  616. DAUNGSUPAWONG H, Wiwanitkit V
    Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment.
    AIDS. 2024;38:613.
    >> Share

  617. DICKSON S, James K
    Trends in HIV preexposure prophylaxis utilization and spending among individuals with commercial insurance.
    AIDS. 2024;38:610-612.
    >> Share

  618. VANDERVEEN LA, Selzer L, Moldt B, Parvangada A, et al
    HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection.
    AIDS. 2024;38:607-610.
    >> Share

  619. LEE D, Capeau J
    Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?
    AIDS. 2024;38:603-605.
    >> Share

  620. ZACCARELLI M
    Reassessing the emphasis on limited options in antiretroviral treatment.
    AIDS. 2024;38:599-601.
    >> Share

  621. WINSTON A, Price P
    Could humoral immune responses to herpesviruses be a pathogenic driver of cognitive disorders in persons with HIV?
    AIDS. 2024;38:597-598.
    >> Share

  622. MASCOLO S, Romanelli A
    A new frontier in HIV care: the predictive power of renal biomarkers on heart health.
    AIDS. 2024;38:595-596.
    >> Share

  623. COLBRUNN DK, Jacks C, Curry SR, Gebregziabher M, et al
    Outcomes of discordant HIV screening test results at a southern academic medical center.
    AIDS. 2024 Mar 14. doi: 10.1097/QAD.0000000000003884.
    >> Share

  624. CROWELL TA, Ritz J, Zheng L, Naqvi A, et al
    Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial.
    AIDS. 2024 Mar 14. doi: 10.1097/QAD.0000000000003881.
    >> Share

  625. FILIP I
    Changing costs of pre-exposure prophylaxis may undermine efforts to curb HIV infection rates.
    AIDS. 2024 Mar 12. doi: 10.1097/QAD.0000000000003883.
    >> Share

  626. DADABHAI S, Chou VB, Pinilla M, Chinula L, et al
    Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial.
    AIDS. 2024 Mar 4. doi: 10.1097/QAD.0000000000003878.
    >> Share

    February 2024
  627. SHIVAKOTI R, Giganti MJ, Lederman MM, Ketchum R, et al
    Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery.
    AIDS. 2024 Feb 26. doi: 10.1097/QAD.0000000000003877.
    >> Share

  628. WILSON IB, Cole MB, Lee Y, Shireman TI, et al
    The relationship of age and comorbid conditions to hospital and nursing home days in Medicaid recipients with HIV.
    AIDS. 2024 Feb 22. doi: 10.1097/QAD.0000000000003870.
    >> Share

  629. WISEMAN RL, Bigos KL, Dastgheyb RM, Barker PB, et al
    Brain N-acetyl-aspartyl-glutamate (NAAG) is associated with cognitive function in older virally-suppressed people with HIV.
    AIDS. 2024 Feb 22. doi: 10.1097/QAD.0000000000003871.
    >> Share

  630. PATEL D, Beer L, Yuan X, Tie Y, et al
    Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men.
    AIDS. 2024 Feb 8. doi: 10.1097/QAD.0000000000003860.
    >> Share

    January 2024
  631. GEORGIADIS N, Papamichail D, Lytras T, Halkitis PN, et al
    The impact of HIV pre-exposure prophylaxis on bacterial sexually transmitted infection occurrence in MSM: A Systematic Review and Meta-analysis.
    AIDS. 2024 Jan 12. doi: 10.1097/QAD.0000000000003837.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016